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ABSTRACT
Lipid peroxidation is the process by which lipids in the cell membrane 
undergo free radical-initiated oxidation. The resulting cell damage has been 
implicated in the onset of many diseases, including as cancer, aging, and 
stroke. Lipid oxidation has been studied in a variety of membrane models, 
including homogeneous solution, micelles, liposomes, and microsomes. The 
kinetics for free radical reactions proven to occur during lipid oxidation in 
homogeneous solution have been thoroughly elucidated. These kinetics 
were also shown to apply to oxidation in micelles. This dissertation 
presents evidence that the kinetics o f more biologically realistic membrane 
models such as liposomes may be quite different. Antioxidants such as a- 
tocopherol (a-T) have been shown to inhibit lipid oxidation. Work presented 
here suggests that the efficiency with which antioxidants inhibit oxidation is 
dependent on the structure of the membrane model. It was observed that the 
antioxidant efficiency of a-T decreases dramatically from homogeneous to 
heterogeneous systems of lipid, including micelles, liposomes, and microsomes. 
This could be due to a decrease in fluidity in the membrane model, limiting the 
diffusion of a-T. A less mobile antioxidant may have fewer opportunities for 
encountering and trapping free radicals. Addition of free fatty acids (FFA) to the 
membrane model to mimic damaged tissue enhanced a-Ts efficiency.
Differential Scanning Calorimetry data show there is an increase in fluidity when 
FFA are present, indicating a-T should then diffuse more readily through the
xi
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membrane. This work thus demonstrates that while a-T appears effective in 
homogeneous solution, micelles, and liposome models of damaged membranes, 
its antioxidant efficiency is much smaiier in bioiogicaiiy reievant modeis for 
normal tissues. Furthermore, the concentration of a-T required to inhibit 
oxidation in liposomes is greater than that which exists in tissues in vivo. Finally, 
the antioxidant effectiveness of several synthetic antioxidant drugs called 
21-aminosteroids was compared with that of a-T. It is shown here that a-T is 
much more effective than any of the 21 -aminosteroids. In addition, the 21 - 
aminosteroids were shown to be much less effective below pH 7.0. This may be 
important in damaged tissue, where the pH reportedly falls to as low as 5.9.
xii
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CHAPTER 1: INTRODUCTION
1
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
21.1. Autoxidation and its biological initiation
It is generally well understood that oxygen is critical to life. Naturally
occurring oxygen exists as a diradical, shown below.1 When this oxygen species
• •
•  •
undergoes one-electron reduction, for example by NADPH to form NADP+, the 
result is an oxygen species with a highly reactive unpaired electron called a free
radical.2 This oxygen species, 0 2'~, is termed superoxide. Superoxide is
involved in and is essential to many important biological processes, including 
the detoxifying reaction of cytochrome P450, phagocytosis, and prostaglandin 
biosynthesis. M
The reduction of hydrogen peroxide can lead to the formation of hydroxyl 
radical (’OH).6 Low levels of hydroxyl radical normally exist in the body.7 This
highly reactive free radical can attack and oxidize almost any component of 
human cells, eventually resulting in cell death.8,9 Fortunately, nature provides 
the body with its own defense - antioxidants - to protect against this oxidative 
damage. Typical antioxidants react with free radicals to produce non-radical 
products and prevent further oxidative damage to tissues.10 Natural 
antioxidants, discussed in length in a later section, include a-tocopherol, 
p-carotene, ascorbic acid, and enzymes such as superoxide dismutase and 
catalase, to name a few .11
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3As long as there is a balance in the body between the formation of free 
radicals and antioxidation, tissues remain healthy. When tissues become 
stressed by any one of a number of factors including ionizing radiation, 
traumatic injury, or inflammation, the production of free radicals exceeds 
antioxidation.12 When this occurs, wide-scale lipid peroxidation results in tissue 
damage.
Lipid peroxidation is a free-radical process in which lipids in cell membranes 
become oxidized and are thus damaged. This cell damage has been implicated 
in cancer, aging, traumatic head injury, atherosclerosis and stroke, to name a 
few .13"15 Figure 1.1 illustrates the reactions for oxidative damage to cell 
membrane lipids that occur during peroxidation. In this figure LH represents
oxidizable lipid and LOO', the highly reactive lipid peroxyl radical resulting from
o
Figure 1.1. Oxidation of the phospholipid fatty acyl side chain.
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oxidative attack. Note that it is the unsaturated fatty acyl side chains of the 
phospholipids in the bilayer membrane that are attacked by free radicals. In 
particular, it is the bis-allylic hydrogen atoms that are abstracted by lipid peroxyl
radicals to produce LOOH and lipid alkyl radical (L'), thus propagating further
oxidative damage.16
Free radicals have been shown to be involved in inflammation.1718 Human 
phagocytes are cells which engulf and destroy cells foreign to the body, such as 
bacteria. Part of the process of destroying these foreign materials is through the 
use of superoxide, generated by the one-electron reduction of singlet oxygen by 
NADPH to yield NADPV9
During inflammation phagocytes tend to produce far more superoxide than 
necessary.5 20 Some of this superoxide can react with protons to form H20 2. and 
0 2 (eq 1.1).11 Though H20 2 alone is not highly reactive, the presence of iron
0 2-  + 2H+ -> H20 2 + 0 2 (1.1)
can initiate lipid peroxidation which damages tissues surrounding the inflammed 
area.21
Iron-dependent lipid peroxidation can be initiated by several mechanisms.22 
First of all, Fe" can undergo autoxidation to Fe"1 to form superoxide (eq 1.2).
The reverse reaction does occur, but it must compete with the dismutation of 
superoxide by superoxide dismutase to form H20 2. Fe" also reacts with H20 2,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
5Fe" + 0 2 -----------** Fe'" + 0 2'  (1.2)
however, by one of the following mechanisms (eqs 1.3,1.4). In this case, ’OH 
and Fe'"OH serve as powerful oxidants for initiating oxidation. Thus, with only
Fe" + H20 2 ------------** Fe'" + ‘OH + OH' (1.3)
Fe" + H20 2 ------------► Fe'"OH + OH' (1.4)
trace amounts of iron in biological systems, the iron-catalyzed Haber-Weiss 
reaction (equations 1.5,1.6) may occur.
Fe'" + 0 2"   ► Fe" + 0 2 (1.5)
Fe" + H20 2 -----------► Fe"' + 'OH + O H ' (1.6)
Iron can additionally react with lipid hydroperoxide (LOOH) formed during 
lipid peroxidation (Figure 1.1) to produce either the lipid alkoxyl radical (LO’) or
lipia peroxyl radical (LOO‘), shown in equations 1.7 and 1.8. The resulting lipid 
peroxyl radical and lipid alkoxyl radical can then react with more lipid to
LOOH + Fe" -----------► LO* + OH' + Fe"' (1.7)
LOOH + Fe"1 -----------► LOO’ + Fe" (1.8)
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
6produce LOOH or LOH and lipid alkyl radical, propagating the chain of free 
radical damage to cell membranes (eqs 1.9,1.10).
LO' + LH ---------- ► LOH + L’ (1.9)
LOO* + LH  ► LOOH + L' (1.10)
Following traumatic injury, various biological reactions occur that ultimately 
result in the proliferation of a large number of free radicals. Traumatic injury 
such as that to the central nervous system eventually results in a condition 
known as ischemia.22 Ischemia is the partial or complete depletion of oxygen to 
a tissue. Following the onset of ischemia a number of cellular metabolic 
activities begin to occur which are conducive to the formation of oxygen free 
radicals. Due to its lack of oxygen, the cell first switches to anaerobic 
respiration.23 As this respiratory pathway is energetically less efficient, the 
levels of ATP decrease dramatically. All available high energy phosphates are 
consumed.23 Due to the onset of anaerobic respiration, the levels of lactic acid 
(a by-product of this process) in the tissues increase.24 Tissue pH thus falls 
from approximately 7.4 to between 5.9 and 6 .4 .25
As ATP is consumed in the ischemic tissue, AMP begins to accumulate and is 
eventually degraded to hypoxanthine.24 Hypoxanthine in normal tissues is 
converted to uric acid by xanthine dehydrogenase.26 During ischemia, however, 
xanthine dehydrogenase is converted proteolytically to xanthine oxidase.27 The
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
xanthine oxidase thus formed catalyzes the production of superoxide via the 
oxidation of hypoxanthine to produce xanthine (Figure 1.2).28 The resulting
20» HzO 20?*,2H*
xanthine oxidase
0
II 20* HzO 20r ',2H* II 
o 0
Hypoxanthine Xanthine Uric Acid
Figure 1.2. Mechanism of superoxide production by xanthine oxidase.
xanthine can again be oxidized by xanthine oxidase to produce uric acid and 
more superoxide, or eventually, H20 2. 28
After the development of these cellular activities return of oxygen to the 
tissue results in a proliferation of superoxide and H20 2 production. 22,27 The 
inevitable consequence is thus lipid peroxidation and tissue damage.
Recently, free radical research has focused on another free radical called
nitric oxide, NO', shown to be important to the body. It was discovered that nitric
oxide is the vasodilator that relaxes smooth muscle in the vessel wall to 
consequently reduce blood pressure. 29,30 It is also important to various other 
biological functions such as neurotransmission, blood clotting, learning and 
memory. 29,30 Though nitric oxide is a relatively unreactive free radical, it can 
react with superoxide to produce the highly reactive peroxynitrite radical, shown 
in eq 11.31-33 This highly reactive free radical has been implicated in oxidative 
damage to membrane lip ids,34 sulfhydryl amino acids,35 and methionine
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
8NO- + 0 2- --------- ► ONOO
.1 1 )
residues.36 It has also been shown to hydroxylate and nitrate aromatic amino 
acids.37,38
1.2. Antioxidation in vivo.
Antioxidants are compounds the body uses to eliminate free radicals. 
Antioxidants are divided into two basic classes based on their mechanism of 
inhibition. Antioxidants which prevent the initiation of oxidation are called 
primary or preventive antioxidants.39 Secondary or chain-breaking antioxidants 
are those which terminate chain-propagating free radicals, such as the peroxyl 
radical.39
A number of enzymes exist in vivo to prevent lipid oxidation. One of these is 
superoxide dismutase (SOD). SOD converts superoxide into the less reactive 
H20 2l as shown in eq. 1.12 below. 40 The hydrogen peroxide is then eliminated
O r' + 2H* s0°  ► h202 ♦ 02 (1 12)
by one of two enzymes - catalase and glutathione peroxidase. Catalase reacts 
with H20 2 to produce H20 and 0 2 (eq 1.13).7,9 Glutathione peroxidase reacts 
with H20 2 in the presence of glutathione (GSH) to produce H20  and oxidized
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
92H202 catala-se »• 2H20  + 02 (1.13)
glutathione (GSSG), as shown in Figure 1.3.741 Glutathione peroxidase has also 
been shown to reduce lipid hydroperoxides, formed during lipid peroxidation, to
Figure 1.3. Mechanism of reduction of H20 2 via the oxidation of glutathione
by glutathione peroxidase.
the less reactive alcohol. Selenium is often considered an antioxidant, because 
it is important to the function of glutathione peroxidase. 42 The oxidized 
glutathione species (GSSG) is then converted back to glutathione by glutathione 
reductase via the oxidation of NADPH to NADP+ (Figure 1.4).7,41
Figure 1.4. Reduction of oxidized glutathione by glutathione reductase.
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? glutathione reductase
10
The body possesses chelating glycoproteins which usually keep iron and 
copper in forms which are not conducive to the initiation of lipid oxidation. Iron, 
for example, is transported through plasma bound to the protein transferrin.43 
Copper, capable of initiating oxidation by a similar mechanism as Fe, is carried 
through plasma by the protein ceruloplasmin.44 In these bound forms, the metal 
ions are not available for initiating free radical reactions.
The body also requires other non-enzymatic natural antioxidants normally 
present in healthy d ie ts.13-45'47 One such antioxidant is a-tocopherol (one of a 
group of tocopherols collectively known as Vitamin E). Antioxidants such as 
a-tocopherol (a-T) are compounds capable of inhibiting the oxidative chain of 
reactions and are thus biologically important. During typical inhibition of lipid
peroxidation by a phenolic antioxidant such as a-T, LOO’ abstracts a H-atom
from the antioxidant to produce a stable and persistent free radical called a 
phenoxyl radical (Figure 1.5).48 The phenoxyl radical can then react with 
another lipid peroxyl radical to produce several possible non-radical products,
CHjho.
+ LOO*
Figure 1.5. Mechanism for antioxidation by a-tocopherol.
one of which is illustrated above.48 BHT (butylated hydroxytoluene), also a 
phenolic antioxidant, is a food additive used to prevent the oxidation of food
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which causes rancidification.49 Its antioxidant activity is believed to proceed by 
the same mechanism as a-T.
Ascorbic acid (Vitamin C) is a water-soluble antioxidant. It has been shown 
to react with H20 2 to produce dehydroascorbate.90 It was shown that a-T and 
ascorbic acid are synergistic antioxidants, in that the ascorbic acid regenerates 
the oxidized a-T into a usable form .5152
Various lipid-soluble carotenoids of plant origin, including (3-carotene (the 
biological precursor to Vitamin A) have been shown to inhibit lipid oxidation in 
LDL (low density lipoprotein).53 Characterization of the oxidation products of 
related carotenoids suggests that the inhibition by (3-carotene is probably due to 
its coupling to lipid peroxyl radicals to form non-radical products. 54
1.3. Kinetic Modeling of lipid peroxidation and its antioxidation.
Important to the study of lipid peroxidation is the use of membrane models. 
Simple and uncomplicated, biologically realistic membrane models allow for a 
quick and easy elucidation of many aspects of both lipid peroxidation and its 
antioxidation. These include the interpretation of the kinetics of lipid 
peroxidation and evaluation of the effectiveness of antioxidants. Figure 1.2 
shows the structure of two membrane models, liposomes and micelles. 
Surfactants such as sodium dodecyl sulfate are conical in structure and 
preferentially assume a spherical micellar structure when placed in aqueous 
solution.55 Phospholipids are tubular in shape and tend to form a bilayer
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Liposomes Micelles
Figure 1.6. Structures of micelles and liposomes.
structure when placed in aqueous solution.55 They align themselves as to 
minimize contact between the hydrophobic hydrocarbon side chains and the 
aqueous layer.55 This bilayer structure is similar to the lipid bilayer of cell 
membranes. The hydrocarbon tails of the bilayer sheet thus formed further 
minimize their contact with water by folding back on themselves to form a hollow 
vesicle known as a liposome.55
Liposomes can be classified as either unilamellar vesicles (ULVs) or 
multilamellar vesicles (MLVs), both of varying sizes. The two liposome models 
studied here are the medium-sized ULVs and large MLVs. As shown in Figure
3.3, unilamellar vesicles contain only one lipid bilayer, while MLVs contain 
several stacked or concentric lipid bilayers. Between micelles, ULVs, and MLVs, 
ULVs are structurally the most biologically similar to the cell membrane.
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Unilamellar Vesicles Multilamellar Vesicles 
(ULVs) (MLVs)
Figure 1.7. Liposomal membrane models.
Systematic kinetic work done in homogeneous solution has elicited the 
reactions shown in equations 1.14-1.19. 56,57 These are the reactions proven to 
occur during lipid peroxidation initiated by an azo compound (R-N=N-R) in 
organic solution. 58,59 Azo compounds are a convenient source of initiating free
radicals, in this case alkyl radicals (R'). Oxidizable substrate (e.g., linoleic acid)
is represented here by LH. The first three equations are those for initiation. In 
these reactions the azo compound decomposes into two alkyl radicals that can 
react with a polyunsaturated fatty acid (linoleic acid) to produce lipid alkyl 
radicals. These lipid alkyl radicals further react with oxygen in aerobic 
conditions to produce lipid peroxyl radicals.
This dissertation suggests that some of the membrane models, such as 
micelles and homogeneous solutions of lipid, used previously by other 
investigators51,58,6&82 are not suitable model systems. Firstly, the two are not 
structurally similar to the cell membrane’s lipid bilayer. Most importantly, the 
kinetics of these two systems are not the same as those of the more biologically 
realistic membrane models studied here - liposomes58,6M5
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Initiation
R-N=N-R -» 2R* + N2 (1.14)
R + LH -► RH + L (1.15)
R + 0 2 -> ROO’ (1.16)
Propagation
LOO' + LH -► LOOH + L (1.17)
L + 0 2 LOO' (1.18)
Termination
2LOO-> Non-radical products (1.19)
Figure 1.5, shown previously in section 1.2, gives an example of H-atom 
abstraction from a-tocopherol, a phenolic antioxidant, to produce a stable 
phenoxyl radical. The phenoxyl radical then reacts with a second LOO‘ to 
produce one of a variety of non-radical products, one of which is illustrated in 
Figure 1.5. 48 The initial H-atom abstraction is the slow, rate-determining step.59 
The rate constant for this step, kjnh, determines the effectiveness of
antioxidants.59 Previous investigators have used this constant, k^, to compare 
the efficiencies of various antioxidants in a variety of membrane models. 58 62-6Ma
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1.4. Release of free fatty acids in lipid peroxidation.
As mentioned earlier in section 1.1, a large amount of superoxide and other 
free radicals are produced during inflammation. It is commonly believed that 
free radicals and prostaglandins are involved in the inflammatory process.1718 
Free radical insult has been shown to stimulate phospholipases to degrade 
phospholipids, liberating free fatty acids (FFA).89 Marion and Wolfe used 
radiolabeled arachidonic acid to determine the source of unesterified FFA in rat 
forebrain post-mortem.70 They determined that it came from a variety of lipid 
sources, including phosphatidylcholine and phosphatidylinositol. 
Phosphatidylcholine and phosphatidylethanolamine are degraded by 
phospholipase A2 to generate arachidonic acid, the predominate FFA observed 
in rat brain tissues following insult.71 After the release of FFA from the 
phospholipid bilayer, cyclooxygenase converts the arachidonic acid to 
prostaglandins and lipid peroxides.18,72 Alternatively, lipoxygenase converts the 
arachidonic acid to hydroxy fatty acids and leukotrienes.18,72 Once introduced 
into cell cultures and tissues, arachidonic acid has been shown to disrupt 
membrane integrity. 68,72 74
1.5. The antioxidant efficiency of the synthetic CNS antioxidant U74006.
It is estimated that each year 1 million Americans suffer from stroke or trauma 
to the head or spinal cord Because no successful therapy exists as yet for 
these central nervous system (CNS)-related injuries, much research into this 
area is currently underway.
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In traumatic CNS injury, the initial insult results in a tearing of the neurons 
and axons, resulting in death of the affected cells.22 At some point after this 
occurs, there is a loss of blood flow to the brain or spinal cord tissue, a condition 
known as ischemia. 75,76 The reintroduction of blood flow and oxygen to this 
tissue, however, results in a sudden burst of oxygen free radicals and thus, lipid 
peroxidation.77 The CNS is particularly prone to oxidative damage due to the 
large percentage of unsaturated lipids that make up the neuronal cell 
membranes.22 There is reportedly also a lack of cellular antioxidants, including 
catalase and glutathione peroxidase, in CNS tissue.7,78 Because of its inability to 
regenerate itself, any damage to CNS tissue results in permanent loss of cell 
and tissue function. Much effort has thus been exerted into developing new 
antioxidants to defend against free radical oxidative damage.
Initially, it was observed that large doses of steroids such as 
methylprednisolone (Figure 1.8) inhibited lipid peroxidation in CNS tissues. It 
was shown that administration of this drug improves recovery from damage to 
the CNS in m ice79 and in cats.80 The problem associated with the use of these 
drugs is that they are known to elicit glucocorticoid activity, including 
hormonally-related elevation of blood glucose levels; immunosuppression, and 
weight loss.81
More recently, a new, but similar class of antioxidants called 21- 
aminosteroids has been developed that lack this glucocorticoid activity.82 Two 
representative compounds from this class include U74500A (pregna-1,4,9(11 )- 
triene-3,20-dione, 21 -[4-[5,6-bis(diethylamino)-2-pyridinyl]-1 -piperazinyl-16-
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HQ ...OH
Na
Figure 1.8. Structure of methylprednisoione.
methyl-,hydrochloride) and U74006F (21-[4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)- 
1 -piperazinyl]-16-methyl-( 16. alpha. )-pregna-1,4,9(11 )-triene-3,20-dione 
monomethanesulfonate mesylate) shown in Figure 1.9. Both contain a 
nonglucocorticoid steroid bound to an amine which serves as its antioxidant 
functionality. While very similar in structure, the two inhibit lipid peroxidation by 
different mechanisms. The U74500A is an iron chelator and thus inhibits iron- 
dependent lipid peroxidation. 83,84 U74006F, though not an iron chelator, is 
capable of inhibiting both iron- and noniron-dependent lipid peroxidation.83,84
Certain pyridine compounds were shown to have affinity for Fe".85 These 
compounds contain a N-C-C-N fragment that enable them form bidentate ligands 
to the metal.86 Similarly, U74500A contains a N-C-C-N fragment that renders it 
an excellent chelator of Fe". As such, it is capable of inhibiting Fe"-dependent 
lipid peroxidation.87 Interestingly, this amine was less effective at inhibiting
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U74500A U74006F
Figure 1.9. Structures of 21-aminosteroids in clinical trials.
oxidation when not bound to the steroid.86 Although most of the iron added to 
lipid systems is located within the more aqueous region of the membrane, it has 
been found that iron can actually bind to the membrane itse lf.88 Steroids, 
including the 21-aminosteroids, are already known to partition themselves within 
the lipophilic region of the membrane. 89,90 The fact that addition of a steroid to an 
iron chelator was capable of increasing its ability to inhibit iron-dependent 
oxidation could suggest that the membrane-bound iron is the actual initiating 
species.
U74006F prevents lipid peroxidation but is not an iron chelator. It was shown 
to exhibit inhibition comparable to a-tocopherol in membranes.91 Both U74006F
and U74500A were proven reactive toward lipid peroxyl radicals (LOO‘) and 
phenoxyl radicals (PhO‘) ,91 and were able to spare a-tocopherol in membrane
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models as well as in vivo. 91,92 An interesting finding was that U74006Fshowed a 
smaller antioxidant effectiveness in systems of arachidonic acid in ethanol than 
in membranes.91 Perhaps the antioxidant role of U74006F includes membrane 
stabilization by the steroid group. This 21-aminosteroid was in fact shown to 
elicit similar effects as cholesterol on lipid packing order in membrane models.90 
In this study, U74006F was proven to have a wide distribution between the two 
layers and contributed to a higher order in lipid packing within the hydrophobic 
lipid domain. Higher order and increased membrane packing may result in the 
entry of fewer free radicals into the lipid bilayer to initiate oxidation.
U74006F was chosen for development in clinical trials for antioxidant 
protection against brain and spinal cord injury, stroke, and brain hemorrhage.93 
Although U74500A in some instances was proven to be a more potent inhibitor 
of iron-dependent lipid peroxidation, it lacks pharmaceutic stability and is rapidly 
eliminated in vivo. 93 It was for these reasons that we chose U74006F for our 
investigation.
1.6. Goals for this research.
The first goal of this study was to compare the kinetics of homogeneous 
solution82 and micelles 58,66 with that of liposomes, whose lipid bilayer makes for 
a better model of the cell membrane. The data and results for work done in this 
area are described in detail in chapter 2. The kinetics of the two liposome 
models presented here, multilamellar vesicles (MLVs) and unilamellar vesicles 
(ULVs), are further compared. Results from these data show that the
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traditionally accepted rate equation determined for homogeneous solution and 
for micelles is not valid in either of the liposome models studied here.
Secondly, the antioxidant effectiveness of a-tocopherol was determined for 
micelles and for MLVs and ULVs. The results are compared to that observed by 
others in the same or different systems. The data show that the effectiveness of 
a-tocopherol decreases from homogeneous solution and micelles to liposomes. 
This indicates that as the membrane model becomes more biologically realistic, 
the antioxidant effectiveness of a-tocopherol decreases. This could suggest that 
a-tocopherol may not actually be very effective in vivo. It was also observed that 
the antioxidant was less effective at high concentrations. This, in conjunction 
with findings by other researchers, may suggest that at high concentrations there 
is a competition between antioxidation and prooxidation by a-tocopherol.
The third goal of this research was to determine the role of free fatty acids in 
lipid oxidation and antioxidation. In chapter 3 we present data that clearly show 
there is an increase in the antioxidant efficiency of a-tocopherol in the presence 
of FFA. This effect becomes important in oxidatively damaged tissue where FFA 
have been shown to be released. 70,94,95
Evidence from differential scanning calorimetry (also in chapter 3) is 
presented here that suggests there is a change in membrane fluidity when both 
a-T and FFA are present. It is possible that an increase in membrane fluidity in 
the presence of FFA is responsible for the increase in a-Ts efficiency in 
liposomes containing FFA. A more fluid membrane may allow for greater 
mobility of a-tocopherol to encounter and trap free radicals.
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Finally, the antioxidant effectiveness of U74006F was compared with that of 
a-tocopherol in systems of noniron-dependent lipid peroxidation in ULV 
liposomes. These data are presented in chapter 4. Results show that there is a 
decrease in the antioxidant effectiveness of U74006 between pH 7.0 and pH 6.5. 
This could indicate that U74006 may not be effective in damaged tissue, where 
the pH was shown to decrease to about 5.4-6.9.25
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CHAPTER 2: EFFECT OF MEMBRANE STRUCTURE ON THE 
KINETICS OF LIPID PEROXIDATION
22
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2.1. INTRODUCTION
Systematic kinetic work done in homogeneous solution has elicited the 
following reactions (eqs 2.1 >2.6), given previously in chapter 1 but repeated here 
for convenience59 These are the reactions generally believed to occur during 
lipid peroxidation initiated by an azo compound (R-N=N-R) in organic 
solution.5859 Oxidizable substrate (e.g., linoleic acid) is represented here by LH.
Initiation
R-N=N-R -» 2R + N2 (2.1)
R +  LH -► RH + L (2.2)
R + 0 2 -► ROO' (2.3)
Propagation
LOO* + LH -> LOOH + L (2.4)
L + 0 2 - *  LOO* (2.5)
Termination
2LOO -> Non-radical products (2.6)
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The first three equations are those for initiation. In these reactions the azo 
compound decomposes into two alkyl radicals that can react with a 
polyunsaturated fatty acid (linoleic acid) to produce lipid alkyl radicals. These 
lipid alkyl radicals further react with oxygen in aerobic conditions to produce lipid 
peroxyl radicals.
Most common biological initiators of membrane lipid peroxidation, for 
example, the hydroxyl radical from the metal-mediated reduction of hydrogen 
peroxide or superoxide, are hydrophilic.7,11 These initiating free radicals form in 
the extracellular medium or at the membrane interface between the lipophilic 
and hydrophilic regions.711 Thus, the radicals must partition into the lipophilic 
region of the membrane at least slightly in order to abstract a reactive bis-allylic 
lipid hydrogen atom and initiate the lipid peroxidation chain process.16
In this study, we have used the cationic, water-soluble azo compound ABAP 
(2,2’-azobis-2-amidinopropane dihydrochloride), shown in Figure 2.1, to mimic 
the hydrophilic nature of most biological initiators. Azo compounds are known to 
decompose unimolecularly at a known and constant rate.96 The decomposition 
of the azo initiator is thus quantitative, making interpretion of the kinetic results 
feasible.58 Many researchers have used ABAP as an initiator in in vitro models 
for membrane lipid peroxidation because of its ease of study. 58,66,97 One 
assumption that is commonly made is that the mechanism of the ABAP 
decomposition is similar to that observed with other azo compounds
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"Cl!
Figure 2.1. Structure of ABAP, a water-soluble azo initiator.
(see eqs 2.7-2.9).58 The first step results in the formation of a caged radical 
complex via either concerted or stepwise bond dissociation (eq 2 .7 ).58 96 The 
caged radicals can then either combine in the cage (eq 2.8) or escape as free 
radicals available for initiating chain processes (eq 2.9).
R N=N—R --------► R- N=N R ' (2.7)
R* N =N  R ' R—R + N2 (2.8)
Previous studies probing the kinetics of lipid oxidation in homogeneous 
solution and in SDS micelles elucidated the rate equation shown in eq 2.10.57 
The rate constants denoted in this equation are those for the free radical
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oxidation reactions described in eqs 2.1-2.6. Here, kp is the rate constant for 
initiation (eq 2.4), k* is the rate constant for termination (eq 2.6), R, is the rate of 
initiation (eq 2.1), and LH is the oxidizable substrate (polyunsaturated fatty acid).
More recently, liposomes are being used as membrane models, because 
their lipid bilayers make for a better model of the cell membrane.98 In aqueous 
solution, two types of liposomes are possible, multilamellar vesicles (MLVs) and 
unilamellar vesicles (ULVs). Unilamellar vesicles are phospholipid spheres 
containing only one lipid bilayer, while MLVs contain several concentric or 
stacked lipid bilayers. ULVs are a more biologically realistic model of the cell 
membrane’s lipid bilayer.
The goal of this study was to determine whether homogeneous kinetics 
applied to more biologically realistic membrane models such as liposomes. The 
results obtained for SDS micelles were compared to results reported in the 
literature for the same system to confirm that the method used here for 
measuring lipid oxidation was valid. Furthermore, comparison of the kinetic data 
obtained for the ULV and MLV membrane models studied here with data 
reported in the literature show that indeed the kinetics of these two systems are 
different from that of other previously studied model systems. Neither MLVs nor 
ULVs seems to abide by the traditionally accepted rate equation.
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2.2. RESULTS
2.2.1. Medium effects on the effective rate of decomposition of ABAP, a 
water-soluble azo initiator.
Rates of oxygen consumption were determined at 37°C as a function of the 
concentration of ABAP (2,2' azobis-2-amidinopropane) in each of the different 
media used in this study (buffer, SDS micelles, MLVs, and ULVs). No 
unsaturated lipids were present in the SDS, MLV, or ULV systems. Tabulated 
raw data for these experiments can be found in the Appendixes, Table A.1.
The rate of decomposition of initiator is represented below as R.. This rate
depends on the rate constant for the decomposition of the initiator, kd, and
Rj = nekd[ABAP] (2.11)
the efficiency, e, which is the fraction of alkyl radicals that react with oxygen to 
produce peroxyl radicals. The stoichiometric factor, n, is assumed to have a 
value of 2, because the decomposition of azo compound results in the 
production of two molecules of free radicals, in homogeneous systems, ne is 
approximately equal to 1.0, and kd for ABAP is equal to 3.72X10 ‘V 1. 58 The 
slope of the lines generated by least squares treatment of rates of initiation (Rj) 
versus [ABAP] gives the quantity nekd (Figure 2.2). From the slope of R* versus 
[ABAP] and with n equal to 2, we can calculate the quantity ekd, which is the
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Figure 2.2. Comparisons of the effect of media on the decomposition of ABAP in 
A) phosphate buffer, B) SDS micelles, C) MLVs, and D) ULVs. Samples contained the following: 
50mM phosphate buffer, pH 7.4,88.3 pM DTPA, B) 0.5 M SDS in phosphate buffer, 88.3 pM DTPA, C) 20 
mg/mL MLV hydrogenated egg PC In phosphate buffer, 88.3 pM DTPA, D) 20 mg/mL MLV hydrogenated 
egg PC in phosphate buffer, 88.3 pM DTPA. Data were obtained using the oxygen electrode method. rooo
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effective rate of formation of radicals available for initiating lipid peroxidation 
chain processes. Thus, we calculate values of ekd at 37°C (Table 2.1) of 3.1 ± 
0.4 X 10‘V 1 and 2.8 ± 0.4 X 10 V 1 in the presence of buffer alone and SDS, 
respectively. In MLVs and ULVs the values were similar, at 2.4 ± 0.3 X 10'7s'1 
and 2.3 ± 0.2 X 10'7s'1, respectively. Calculations for comparison of the means 
at 95% confidence were performed on these data.99 These calculations show 
that ekd for MLVs and ULVs is different from that of buffer. In addition, values for 
ekd in micelles and buffer were statistically the same. Figure 2.3 illustrates these 
results graphically.
Table 2.1. Results fo r measuring the dependence o f media on the rate o f 
decomposition o f ABAP in buffer, micelles, MLVs and ULVs.* __________
Figure 2.3. Error associated w ith calculated values o f ekd in various
membrane models.
Model System
phosphate buffer 
SDS micelles 
MLV hydrogenated PC 
ULV hydrogenated PC
ekd ± cj (X107 s"1) 
3.12 + 0.43 
2.83 ± 0.43 
2.40 ±0.30 
2.28 ±0.23
Data obtained from the slopes of the lines generated from data in Figure 2.1.
4-
0- Buffer Micelles MLVs ULVs 
Membrsne Model
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2.2.2. Effect of [ABAP] on rates of oxidation in micelles, MLVs and ULVs.
Rates of oxygen consumption, R^, were determined for different
concentrations of ABAP in various membrane models, this time containing 
oxidizable substrate. Experiments were done in SDS micelles containing linoleic 
acid, and in ULVs and MLVs prepared from soy PC. Tabulated raw data for 
these experiments can be found in Table A. 2 of the Appendixes. Log-log plots 
of log(Rox) versus log([ABAP]) were constructed for each model system and are 
shown in Figure 2.4. The slope of these plots gives the order for ABAP in each 
of the systems. These results are tabulated in Table 2.2.
Table 2.2. Results obtained for measuring the order in ABAP for SDS,
MLVs, and ULVs.*______________________________________________
* Data were obtained for slopes of lines generated in the graphs in Figure 2.2.
2.2.3. Effect of the concentration of unsaturated lipid, [LH], on the rate of 
oxidation in micelles, MLVs, and ULVs.
Log-log plots were constructed for data collected in systems containing 
varying concentrations of MLV and ULV soy PC diluted with 20 mg/mL 
hydrogenated egg PC (unoxidizable lipid) (Figure 2.5, with tabulated raw data in
Membrane Model
SDS micelles 
MLVs 
ULVs
Order+ ct
0.43 ± 0.02 
1.37 ±0.10 
1.35 + 0.18
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Figure 2.4. Decomposition of ABAP in various membrane models containing unsaturated lipid.
Varying concentrations of ABAP (0-15 mM) were added to samples containing A) 0.5 M SDS micelles in phosphate buffer,
88.3 pM DTPA, 46.7 mM linoleic acid, B) 20 mg/mL MLV soy PC in buffer, 88.3 pM DTPA, C) 20 mg/mL ULV soy PC in
88.4 buffer, 88.3 pM DTPA. Data were obtained using the oxygen electrode method.
I
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■6*0
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£
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I  -7.5:
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Figure 2.5. Effect of varying oxidizable substrate 
concentration on the rate of decomposition of ABAP in 
A) MLVs, and in B) ULVs. Both systems contained varying 
amounts of soy PC diluted with 20 mg/mL hydrogenated egg PC in 50 
mM phosphate buffer, pH 7.4,88.3 nM DTPA, and 21.2 mM ABAP. 
Rates of oxidation were measured using the oxygen electrode method.
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Table A. 3 of the Appendixes). The slope of this line gives the order in LH. 
Results show that the order in both systems is less than 1 (Table 2.3). The two 
systems appear to be kineticaiiy different, in that the calculated order in MLVs 
(0.76 ±0.10) is significantly different from the order in ULVs (0.17 ± 0.10). 
Calculations for comparison of the means at 95% confidence99 show that the two 
values for the order in LH are stastically different.
Table 2.3. Results for measuring the order in LH in MLVs and ULVs.*_____
Membrane Models Order ± o
MLVs 0.76 ±0.10
______________ ULVs__________________________ 0.17 ±0.10___________
* Data were obtained from the slopes of the lines generated from the data in Figure 2.3.
2.2.4. Effect of [OJ on rates of oxidation in MLVs and ULVs.
The effect of oxygen concentration on rates of oxidation in MLVs and ULVs is 
shown in Figure 2.6. Rates of oxygen consumption were determined in both 
MLVs and ULVs containing oxygen concentrations of 62.5, 250 and 1250 pM. 
Tabulated raw data from this study can be found in the Appendices in 
Table A. 5. Log-log plots were constructed using rates of oxidation and [O2] 
(Figure 2.6). The slope of the line generated by least squares for the MLV 
system 0.09 ± 0.05 was greater than that for the ULV system, 0.05 ± 0.01 (Table 
2.4). Calculations for comparison of the means at 95% confidence99 show that 
these two numbers are not different. Using this same calculation, however, the 
two orders in 0 2 for the same two systems is statistically different from zero.
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Figure 2.6. Effect of varying oxygen concentration on initiation by ABAP in ULVs.
System contained 20 mg/mL ULV soy PC in 50 mM phosphate buffer, pH 7.4, 88.3 pM DTPA, and 21.2 mM 
ABAP. Samples were bubbled with gas of varying 0 2 concentrations. Rate of oxidation were measured 
by oxygen electrode method.
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Table 2.4. Results for measuring the order in [OJ in MLVs end ULVs. 
Membrane Model Order ± a
MLVs 0.09 ±0.05
_____________ ULVs__________________________ 0.05 ±0.01
* Data were obtained from siopes of ihe lines generated from the data in Figure 2.6.
2.3. DISCUSSION
2.3.1. Rate of intiation resulting from ABAP decomposition in micelles, 
MLVs and ULVs.
It has often been assumed that the decomposition chemistry and kinetics of 
ABAP are essentially independent of its environment.10a101 The results 
presented here tend to suggest that such assumptions are not always justified. 
Apparently, SDS micelles (containing no oxidizable substrate) do not have an 
appreciable effect on ABAP decomposition; the product of the rate constant for 
decomposition and the efficiency is the statistically the same in this system as in 
buffer alone (Figure 2.2). Statistical analysis of data do show, however, that the 
decomposition of ABAP in MLVs and ULVs (also containing no oxidizable 
substrate) is different from its decomposition in buffer alone.
Strickland, Pryor, et a l56 reports a value of kd equal to 3.7 X 10'7s'1 for ABAP 
in micelles. Using the value of e they reported, 0.49, kd is thus calculated to be 
5.7 X 10*7 s'1. From the slopes of the lines shown in Figure 2.1 and assuming 
the stoichimetric factor n equal to 2, ekd was calculated. The results are 
presented in Table 2.1. These results show that the rates of decomposition of 
ABAP in MLVs and ULVs are different from the rates of decomposition in buffer
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and micelles. The decomposition of ABAP thus does not appear to be 
independent of the environment or media.
The order in LH was determined by measuring the rates of oxidation for 
varying concentrations of unsaturated lipid (Table 2.3). The orders in LH for 
MLVs and ULVs are statistically different and are different from 1, the order in 
LH for homogeneous solution.
Barclay, et al, have reported attempts at elucidating the kinetics of azo- 
initiated liposome systems.102 They argue that the rate law confirmed for 
homogeneous systems (determined for eqs 2.1-2.6 and given in eq 2.10) holds 
for liposomes, since they were able to calculate an order of 1.07 in LH and 0.54 
in ABAP. There are two problems with these data. First of all, the order in 
ABAP was calculated in MLVs prepared by vortex-stirring followed by freeze- 
thaw. The order in LH, on the other hand, was determined in ULVs prepared by 
passing the liposomes through a French pressure cell. The first problem with 
Barclay’s experiments is that he assumes the kinetics of ULVs and MLVs are the 
same. The results presented here show a large difference in the kinetics of ULV 
and MLV systems. The second problem with Barclay’s study is that the ULVs 
prepared using the French pressure cell are very small, on the order of 15-30 
nm 103. The liposomes prepared using the extrusion method, as was utilized 
here, are much larger, with a diameter of about 70 nm 1M. The kinetics of these 
two systems should therefore be different, since the fluidity of the liposome 
system decreases as the size of the ULV increases.105'108 As will be discussed in 
chapter 3, fluidity of the membrane model has a large effect on the kinetics of
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the system. The small ULVs prepared by Barclay and his coworkers would thus 
be more fluid and more kinetically similar to homogeneous solution.
In summary, it is likely that the kinetics for oxidation in MLVs and ULVs are 
quite different. This work also suggests that the traditional rate equation 
reported for homogeneous solution and for micelles does not necessarily apply 
to liposomes.
2.4. EXPERIMENTAL
2.4.1. Materials.
Linoleic acid (cis.cis-9, 12, octadecadienoic acid) and 
diethylenetriaminepenta-acetic acid (DTPA) were obtained from Sigma 
Chemical Co. Hydrogenated L-a-phosphatidylcholine from frozen egg yolk was 
purchased from Avanti Polar Lipids (Alabaster, AL). A convenient and 
inexpensive source for the soy phosphatidylcholine used in this study was found 
to be commercial L-<x-Lecithin capsules, purified as described below. Granular 
2,2' azobis-2-amidinopropane dihydrochloride (ABAP), type V-50, was obtained 
from Wako Pure Chemical Industries, Ltd. These, and all other incidental 
chemicals and solvents, were of high purity and were used as received.
2.4.1.1. Purification of L,a lecithin.
The flash chromatography column apparatus was obtained from Ace Glass, 
Inc. (cat. no. 5872). It consisted of a column with a 10 mm I.D. and a 45.7 cm 
effective length, a 250 mL reservoir, and a flow control adapter. A chloroform
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slurry containing 40 g silica gel was poured into the column such that the column 
bed was 35-37 cm in length.
One iecitnin capsuie was dissolved in 10 mL chioroform and ioaded onto the 
column. The column was then pressurized using nitrogen (> 10 psi) such that 
the flow rate was approximately 10 mL/min. The column was first eluted with 400 
mL ethyl acetate/methanol (50:50). This fraction presumably contained less 
polar compounds such as a - tocopherol, (3 - carotene, and diglycerides. The 
PC was then eluted off the column using 200 mL methanol. The methanoiic 
solution was evaporated to dryness under vacuum leaving the purified lipid as a 
thin film on the walls of the flask. The yield was approximately 200 ± 75 mg, 
depending on the source of lecithin. The purified material was dissolved in 
chloroform and was stored under nitrogen at -20°C.
2.4.1.2. Analysis of the purified phosphatidylcholine.
The purity of the sample was confirmed using reverse-phase HPLC and 
comparison to a 99% soy PC sample. A Perkin-Elmer Series 410 pump with a 
235C diode array detector were used. The column used was a Spherisorb 25 
cm X 4.6 mm I.D. Cs reverse-phase column with 5 pm particle size (Regis, 8210
Austin St., Morton Grove, IL, 60053). A solvent mixture consisting of 90% 
acetonitrile and 10% water was formed using the HPLC pump. Conditions for 
the separation included a 1.0 mL/min flow rate run isocratically at 25°C and UV 
detection at 215 nm. Data were collected and analyzed using LabCalc software 
(Galactic Industries).
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The HPLC chromatograms obtained for the soy PC purified as described 
above and for a commerical sample of soy PC (99% purity) are shown in Figure
2.7. Both chromatograms show a similar group of peaks that elute from 14-23 
min. These peaks reflect the mixture of phosphatidylcholines having various 
fatty acid composition (probably of varying degrees of unsaturation). One 
additional large peak was observed at 26.5 min in the commercial soy PC 
sample that was not observed in the purified soy PC. In addition, several small 
impurity peaks were observed between 5 and 15 min in the commercial sample 
that were not observed for the chromatographically purified PC. The peak 
eluting at 3 min in both samples was shown to be due to solvent passage.
Based on the HPLC analysis, it appears that the PC purified by this method is of 
higher purity than PC obtained commercially. However, note that the size of the 
peaks observed with UV detection is not directly indicative of the quantity of 
material present.109,110
Fast-atom bombardment-mass spectra (FAB-MS) were aquired using a 
Finnigan MAT TSQ - 70 triple quadrapole mass spectrometer with an Antek PS- 
4 cesium ion gun. Samples were applied to both glycerol and 3-nitrobenzyi 
alcohol matrices and each were run separately. Sample mixing was 
accomplished by placing the matrix material on a stainless steel probe tip and 
applying the sample to the matrix. The heater current for the Cs pellet was run 
at 150 pA, the extractor at 2.5 kV, the focussing lens at 5.5 kV, and the 
acceleration voltage at 6.4 kV.
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Figure 2.7. HPLC chromatogram fo r L-a- 
phosphatidylcholine. Samples contained A) 100 mg/mL 
chloroform solution of 99% L-a-phosphatidylcholine, and B) 20 
mg/mL chloroform solution of L-a-phosphatidylcholine purified 
from lecithin.
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The chromatographically-purified soy PC, Figure 2.8, gave FAB-MS that 
show mass clusters centered at 695.9, 717.9, 739.0, 759.1, 783.2, and 805.2 
m/e while the commercial soy PC sample showed mass clusters centered at 
759.1 and 783.1 m/e.
Table 2.5 shows the fatty acid composition of some common phospholipids, 
including PC extracted from soybean. Possible combinations for fatty acyl side 
chains that wouid have combined masses corresponding to the mass clusters 
observed by FAB-MS were calculated (Table 2.6). The presence of the cluster
Table 2.5. Fatty acid com position of commonly used phospholip ids55
Fatty acid 
abbreviation
Common
name
Percent abundance (%) in 
natural source o f PC
Soy PC Egg PC Rat PC
14:0 myristic
16:0 palmitic 17.2 35.3 28.8
18:0 stearic 3.8 13.5 18.0
18:1 oleic 22.6 26.8 8.4
18:2 linoleic 47.8 5.7 19.4
18:3 linolenic 8.6 0.2
20:3 1.0
20:4 arachidonic 1.0 17.0
20:5 3.6 2.4
22:5 1.3 1.5
22:6 12.6 3.5
at 805.2 m/e in the FAB-MS of the purified soy PC indicates that this sample 
contained more arachidonic acid (20:4) than did the commercial sample. Since 
no arachidonic acid should be present in soy PC (Table 2.5), PC from some 
other source may have been added to the commercial lecithin capsules. The 
peak with mass 717.9 m/e for the purified lecithin is likely another phospholipid
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Figure 2.8. FAB-MS obtained fo r A) 99% L-a-phosphatidylcholine, and B) 
L-a-phosphatidylcholine purified from a lecithin capsule.
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Table 2.6. Possible combinations of Ri, R2 for the observed FAB-MS mass 
clusters.
Mass cluster Possible Ri, R2 
combinations
Mass
759.1 16:0/18:0 761
16:0/18:1 759
16:0/18:2 757
16:0/18:3 755
783.1 18:0/18:1 789
18:0/18:2 787
18:0/18:3 785
18:1/18:2 783
18:1/18:3 785
18:2/18:3 783
18:0/18:0 781
18:1/18:1 781
18:2/18:2 779
18:3/18:3 777
805.2 20:4/18:0 809
20:4/18:1 807
20:4/18:2 805
20:4/18:3 803
of the same family but is not identified here. Note that the masses reported by 
FAB-MS are one mass unit greater than the actual mass because the analyzed 
species are protonated. Also, as is true of UV detection, size of the peak 
produced by FAB-MS is not necessarily proportional to the quantity present.111
It is likely that the purification procedure reported here results in a purer 
lecithin sample than was available in the particular commercial sample used as a 
standard. Evidence of this was the appearance of the extra impurity peaks 
observed in the HPLC chromatogram for the commercial sample. From the MS
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data, however, its fatty acid composition appears slightly different. Although the 
FAB-MS showed that the two samples contained different types of fatty acyl side 
chains, their properties should be the same.
2.4.2. Methods.
2.4.2.1. Preparation of multilamellar and unilamellar vesicles.
To produce multilamellar vesicles (MLVs) the suspension of soy PC in buffer 
was sonicated in a low energy bath-type sonifier for 5 min, making sure that all 
PC on the sides of the flask were in solution.112 Liposomes produced in this 
manner are very large and heterogeneous in size, on the order of 0.1-5.0 pM in 
diameter.98 For unilamellar vesicles (ULVs), the sample was then extruded 10 
times or until clear through 2 X 100 nm polycarbonate filters using an Avestin 
liposome extrusion device (Ottawa, Canada).104 ULVs prepared using this 
method have been shown to be on average about 70 pM in diameter.104
2A.2.2. Measurement of the effect of SDS micelles and 
phosphatidylcholine liposomes on the rate of decomposition of ABAP.
The rate of decomposition of ABAP was first determined in 50 mM potassium 
phosphate buffer, pH 7.4. This was accomplished by placing 3 mL of the 
phosphate buffer (containing 88.3 nM DTPA) in a Clark-type oxygen electrode 
cell. DTPA (diethylenetriaminepenta-acetic acid ) was added to chelate any iron 
present that may initiate iron-dependent lipid oxidation. The Biological Oxygen 
Monitor, Model YS I5300 (Yellow Springs Instrument Co., Yellow Springs, Ohio)
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was interfaced to computer software via a 12 bit A/D converter. Oxygen 
concentration was thus followed over time. Increasing amounts of 0.5 M ABAP 
in water were added (a few pL at a time), and after each addition, oxygen 
concentration was followed. Rates of oxidation (R«) were determined from the 
slopes of lines generated from plots of oxygen concentration versus time. A plot 
of Rox versus [ABAP] was then constructed and its slope was measured.
To determine the effect of SDS micelles or PC liposomes on the rate of 
decomposition of ABAP, a 3 mL solution of either 0.5 M SDS or 20 mg/mL 
hydrogenated soy PC in 50 mM potassium phosphate buffer, pH 7.4, was 
prepared. MLVs or ULVs were then prepared from soy PC using the methods 
described previously, section 2.4.2.1. DTPA was added so that its final 
concentation was 88.3 (iM. Increasing volumes of 0.5 M ABAP in water were 
added (a few pL at a time), and after each addition, the rate of decrease in 
oxygen concentration was followed.
2.4.2.3. Measurement of the effect of [ABAP] on rates of oxidation in SDS 
micelles, MLV, and ULVs.
To determine the effect of [ABAP] on rates of oxidation in SDS micelles or soy 
PC liposomes, a 3 mL solution of either 0.5 M SDS or 20 mg/mL soy PC in 50 
mM potassium phosphate buffer, pH 7.4, was prepared. MLVs or ULVs were 
then prepared from soy PC using the methods described in section 2.4.2.1.
DTPA was added so that its final concentation was 88.3 pM. To the samples 
containing SDS, linoleic acid was added so that its final concentration was 46.7
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mM. Increasing amounts of ABAP in water were added (a few pL at a time), and 
after each addition, the rates of oxidation were measured as described in section
24.2.2.
2.4.2.4. Measurement of the effect of [LH] on rates of oxidation in MLVs 
and ULVs.
To determine the effect of oxidizable substrate concentration, 3 mL solutions 
of varying concentrations of soy PC diluted with 20 mg/mL hydrogenated egg PC 
were prepared in 50 mM potassium phosphate buffer, pH 7.4. The solutions 
were then either sonicated in a sonic bath (for MLVs) or extruded (for ULVs), as 
previously described. A 2.7 mL aliquot of the solution was then placed in an 
oxygen electrode cell. Stock solutions DTPA and ABAP in buffer were added, so 
that their final concentrations were 88.3 pM and 21.2 mM, respectively. The 
concentration of oxygen was followed over time. The rates of oxidation, Rox, were 
determined as described in section 2.4.2.2. Plots of the rate of oxidation versus 
[LH] were constructed.
2.4.2.5. Measurement of the dependence of oxygen concentration on rates 
of oxidation in MLVs and ULVs.
Solutions of 20 mg/mL ULV or MLV soy PC in phosphate buffer were 
prepared as described previously. These solutions were maintained at 62.5,
250 and 1250 pM 0 2 by bubbling each with gas of varying 0 2 concentrations (5, 
20, and 100%, respectively). The 5% 0 2 gas contained an 0 2/N2 mixture, the
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20% 0 2 gas was a typical air mixture, and the 100% gas contained pure 0 2. The 
concentration of oxygen in the sample was estimated using the assumption that 
air-saturated solution contains 250 nM 0 2t 113 and that air itself is 20% 0 2. The 
concentration of 0 2 in samples bubbled with 5% 0 2 is 62.5 pM; with 20% 0 2, 250 
pM; and with 100% 0 2l 1250 pM. Stock solutions of DTPA and ABAP in 
phosphate buffer were added so that their final concentrations were 88.3 pM and 
21.2 mM, respectively. The rate of oxygen consumption was then measured by 
oxygen electrode method.
2.4.2.6. Error analysis for the oxygen electrode method.
The oxygen electrode method described previously included error that was 
associated with that of the A/D converter, solution preparation, drift of the 
electrode itself, and error from imperfections in the electrode membrane. Each 
of these instrumental errors analysis is listed in Table 2.7. As long as the 
measurement was performed over a short period of time, all of these errors 
should be very small in comparison to that derived from the imperfections in the
Table 2.7. Instrumental error associated with the oxygen electrode method. 
Source of error Percent error
A/D converter ± 0.02%
solution preparation ± 0.32%
drift of electrode ± 0.13% per 15 min
Physical imperfections in membranes_______________ ± 10%_____________
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membrane, which is reportedly 10%. Thus, the total error associated with the 
use of the oxygen electrode over a 15 minute period can thus be assumed to be 
±10.47%.
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STRUCTURE ON ANTIOXIDANT EFFICIENCY OF 
a-TOCOPHEROL
49
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3.1. INTRODUCTION
As discussed in Chapter 1, the inhibition of lipid peroxidation by a phenolic 
antioxidant occurs due to competition between chain propagation (eq 3.1) and 
H-atom abstraction from an antioxidant (eq 3.2) to produce a stable and
LH + LOO' -> L* + LOOH (3.1)
ArOH + LOO' -> ArO' + LOOH (3.2)
persistent phenoxyl radical (ArO*). The phenoxyl radical can further react with a
second LOO’ to produce a non-radical product (illustrated in Chapter 1, Figure
1.1). The initial H-atom abstraction is the slow, rate-determining step. Previous 
investigators measured the rate constant for this step, kjnh, in order to compare 
the effectiveness of antioxidants. This constant was calculated using the rate 
equation (eq 3.3) determined for inhibited oxidation in homogeneous
Ro*,™ = kpRifLHI. (3.3)
2M ArO H ]
solution. In order to calculate kw,, kp, the rate constant for the propagation 
reaction (eq 2.4), and Ri, the rate of initiation (eq 2.1), would first have to be 
experimentally determined. This problem can be alleviated by instead 
calculating an antioxidant efficiency, AE. Antioxidant efficiency is
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mathematically defined as K J K  and has been calculated as such in previously 
reported work.66 The method used here to calculate AE assumes as little
LOO- + LH L- + LOOH (3.4)
LOO- + ArOH kinh»  ArO - + LOOH (3.5)
knowledge about mechanism as possible. In these calculations the "50% 
inhibition concentration" is first determined experimentally. This is the 
concentration of antioxidant required to produce a 50% decrease in the rate of 
oxidation. An assumption about the kinetics of the system is then made in order 
to calculate AE without first calculating kw, or kp. When the rate of lipid 
peroxidation is inhibited by an antioxidant by 50%, the rate of the reactions in 
eqs 3.4 and 3.5 are assumed to be equal and, therefore, kp and kw, are equal. If 
this assumption is accurate, then eqs 3.6 and 3.7 must also be valid. In these
equations, [LH]so and [ArOH]so represent the concentrations of oxidizable lipid 
and phenolic antioxidant at 50% inhibition, respectively.
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kp[LH]5o[LOO-] = k,nh[LOO'][ArOH] so (3.6)
kinh _ [LH]S0
(3.7)kp [ArOHfco
This work demonstrates that the antioxidant efficiency (AE) calculated in this 
manner for a-tocopherol decreases dramatically from homogeneous to 
heterogeneous systems of lipid, such as micelles, liposomes, and microsomes.
In addition, it is concluded that free fatty acids actually enhance AE for a- 
tocopherol. This becomes important in damaged tissue, where free fatty acids 
have been shown to be released. 70,94 To determine what effect FFAs have on the 
membrane that enhances a-tocopherol’s antioxidant efficiency, physical 
characteristics of the liposome before and after addition of FFA were 
investigated.
An electron spin resonance (ESR) assay was used to measure the 
entrapped or internal volume of the liposome vesicle. In this assay the 
liposomes were prepared containing the stable nitroxyl radical TEMPOL (Figure
3.1). Due to its membrane permeability, TEMPOL partitions both within the
OH
Figure 3.1. Structure of TEMPOL, a membrane permeable nitroxyl radical.
aqueous interior of the vesicle, as well as outside the vesicle in solution.114 A 
relatively membrane impermeable spin-label broadening agent, 
tris(oxalato)chromate(lll), is then added. This paramagnetic ion reportedly
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remains only on the outside of the liposome115116 Spin-label broadening agents 
work by both spin exchange and through dipole-dipole interactions.117118 Spin 
exchange occurs as a result of a contact interaction, and dipole-dipole, a 
pseudocontact interaction.117118 In both cases, shorter relaxation times are the 
overall result and line broadening occurs. ESR signal represented by the 
extravesicular nitroxyl radical is thus broadened by the chromium oxalate (Figure
3.2). Chromium oxalate is added in increasing concentrations until no further 
broadening occurs. The signal thus reaches a limiting minimum peak height in
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Tempol Tempol
TempolTempol
Tempol
Tempol
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♦ Cr (III)
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Figure 3.2. Method of measuring entrapped volume in liposome vesicles 
using the nitroxyl radical TEMPOL and the paramagnetic ion Cr (III).
the presence of Cr (III). The signal that remains is that of the TEMPOL within 
the vesicle, and the intensity of the remaining signal is manipulated to determine 
entrapped or internal volume within the liposome vesicle. If the membrane 
becomes leaky, signal from intravesicular TEMPOL may then become 
broadened by Cr (III) that has permeated the membrane, and the effective 
entrapped volume or observed signal should thus be smaller. In these studies,
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entrapped volume was determined for ULVs with and without FFAs to detect 
differences in entrapped volume and/or “leakiness” of the membrane.
Differential scanning calorimetry (DSC) is often used to measure membrane 
flu id ity .119-121 There are two phases that can exist in the liposome - the more 
ordered gel state and the less ordered or more fluid liquid crystalline state. DSC 
is used to measure the temperature of the transition from one phase to another 
and the enthalpy of this transition. Shifts in the liposome’s gel to liquid crystal 
transition temperature or enthalpy correlate to a change in membrane fluidity. 
Results show that when FFAs are present the liposome is more fluid.
3.2. RESULTS
3.2.1. Comparison of inhibition by a-tocopherol in micelles and in 
liposomes.
Plots of percent inhibition versus concentration of a-tocopherol in systems of 
ABAP-initiated oxidation in SDS micelles, and MLV and ULV soy PC liposomes 
showed that inhibition in these systems were not similar (Figure 3.3, with 
tabulated raw data listed in Table A. 5 of the Appendixes). Inhibition in the SDS 
micelles increased to 90 ± 4 % at 10 pM a-T and then decreased gradually. 
Inhibition in the MLV system increased to 108 ± 2 % around 25 |iM and then 
decreased more dramatically. In the ULV system inhibition increased to 115 ±
15 % at 75 piM before its sharp decrease in inhibition.
Note that in calculating the rates of oxidation, the rate of decomposition of 
ABAP (determined in the same system, except with no oxidizable substrate
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Figure 3.3. Inhibition by a-tocopherol in A) SDS micelles , and in 
two liposomes models, B) unilamellar vesicles (ULVs) and 
multilamellar vesicles (MLVs). Sample A) contained 0.5 M SDS, 46.7 mM 
linoleic acid, 88.3 nM DTPA, and 20 mM ABAP. Samples B) and C) contained 20 
mg/mL ULV or MLV soy PC, 21.2 mM ABAP, and 88.3 |iM DTPA. Rates of oxidation 
were measured using the oxygen electrode.
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present) was subtracted from the rate of oxidation measured by the electrode. 
These rates of decomposition are described in chapter 2, Figure 2.2. The 
purpose of this calculation was to describe the rate of oxidation as only that 
derived from the oxidation of the membrane. The ratio of k,nh to kp was 
calculated by dividing the initial concentration of the total oxidizable lipid 
substrate by the 50% inhibition concentration. These 50% inhibition 
concentrations are shown in Table 3.1.
Based on the percent inhibition versus concentration plots, a-tocopherol was 
much less efficient in ULVs than in MLVs or micelles. In fact, the 50% inhibition 
concentration calculated for a-tocopherol in ULVs is an order of magnitude 
greater than that in micelles (Table 3.1). It is also about five times greater than 
that for MLVs.
Table 3.1 Inhibition data for a-tocopherol in various membrane 
models.
Membrane Model 50% Inhibition 
Concentration 
(pM)
Estimated AE 
(D-H]5 o/[ArOH]5o)
SDS micelles 2.0 ±0.6 24,000
MLV Soy PC* 7.2 ±6.2 3500
ULV Soy PC' 36.4 ±5.2 700
ULV Soy PCb 60.5 ±14.7 100
a. 20 mg/mL soy PC in phosphate buffer, b. 5 mg/mL soy PC in phosphate buffer.
The 50% inhibition concentration determined for a-tocopherol in SDS 
micelles is 2.0 ± 0.6 pM. This is comparable to the value obtained by Strickland,
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Pryor, et a l.58 Using the same concentrations of SDS, ABAP, and LH, they 
obtained a value of approximately 3 joM.
Antioxidant efficiencies ([LH]50/[ArOH]50 ratios) observed in SDS micelles and
several different liposomal systems, including those from the literature, are given 
in Table 3.2. The AE ([LH]50/[ArOH]50 ratio) calculated from data reported in the 
literature for inhibition in SDS micelles is an order of magnitude less than the AE 
calculated from data presented here for the same system. Interestingly, the AE 
calculated for inhibition data presented here for micelles is very similar to the AE 
calculated from data reported for homogeneous solution. Another interesting 
trend was observed for AE results within the liposomal group. There is 
apparently a trend to lower AE as the system changes from MLVs to ULVs 
prepared at high phospholipid concentration (20 mg/mL) to ULVs prepared at 
low phospholipid concentrations (5 mg/mL).
One discrepancy between the method for calculating AE presented here, 
where AE = [LH]so/[ArOH]so, and the traditional calculation using the rate 
equation for homogeneous kinetics is apparent for the SDS system (Tables 3.1,
3.2). The antioxidant efficiency calculated using the [LH]so/[ArOH]so ratio for 
SDS micelles was 24,000, but using the traditional calculation (AE = IWkp), AE 
for micelles was instead 4300.
3.2.2. Effect of free fatty acids on inhibition by a-tocopherol in liposomes.
Concentrations of a-tocopherol required to produce a 50% decrease in the 
rate of lipid peroxidation were compared for liposomal systems with and without
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Table 3.2. Antioxidant Efficiencies fora-Tocopherol in Various 
Heterogeneous and Homogeneous Systems.______________
System Estimated AE 
([LHWEArOH]*,)
Reference
Homogeneous
18:2/t-BuOH /AIBN a
Micelles
18:2/SDS/ABAP b
12,400
24,000
Niki, et al62
18:2 / SDS/ABAPC 1830 Pryor, Wu, et al“
18:2/SDS/ABAPd 1000 Pryor, Strickland, et al58
18:2/SDS/TBHNe 600 Pryor, Strickland, et al58
Membrane Models
MLVs / ABAPf 3500
ULVs /A B A P /18:09 2600
ULVs / ABAPh 700
ULVs/ABAP' 100
microsomes / ABAPi 109 Krinsky, et a l67
a. Results tabulated from data obtained for 3.99 M AIBN, 0.604 M LH in t-butyl alcohol, and 
0.272 -1.71 pM Vitamin E. Rate of oxidation was measured using a pressure transducer, b. 
This work. c. Data reported for 0.1 M SDS in 0.3 M phosphate buffer, pH 7.4,2.6 mM LH, and 
0.5 M ABAP. Oxidation was measured by following conjugate diene formation, d. Calculated 
from data reported from using 0.5 M SDS in 0.5 M phosphate buffer, pH 7.6,46.7 mM 18:2, 
4.85-5.24 mM ABAP, and 0.97-1.95 |iM Vitamin E. e. Results obtained using 0.015 M SDS in 50 
mM sodium phosphate buffer, pH 7.0,3 mM 18:2, and 0.3 mM di-tert-butyl hyponitrite. Data 
were aquired using a Clark-type oxygen electrode, f. Used 20 mg/mL MLV soy PC. g. Used 5 
mg/mL ULV soy PC in phosphate buffer with 100 ^M 18:0. h. Same as f., except ULV liposomes 
were used. i. Same as g., except no 18:0 was added, j. Results reported using 25 mM ABAP, 
0.5 mg/mL microsomes in 0.1 M phosphate buffer, pH 7.5, and 2.5 - 9.0 nmol/mg Vitamin E.
Data were obtained by following malonaldehyde (TBARS) formation. All original work presented 
in this paper done using a Clark-type oxygen electrode.
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added free fatty acid (Tables 3.2 and 3.3). Tabulated raw data for this 
experiment can be found in the Appendixes, Table A.6. The systems containing 
free fatty acid required less a- tocopherol for inhibition than those without FFA. 
The model containing 5 mg/mL soy PC and 100 pM oleic acid (Figure 3.4) 
showed that at lower concentrations the added free fatty acid increased 
inhibition substantially. At a-tocopherol concentrations greater than 150 pM 
percent inhibitions calculated with and without FFA were about the same.
Table 3.3. Effect o f Free Fatty Acids on the 50% Inhibition Concentrations 
fo r Vitamin E in Various Liposome Systems.________________________
System FFA 50% Inhibition 
Concentration 
(uM)
Estimated AE 
([LH]so/[ArOH]5o)
SDS micelles 18:2 1.98 ±0.56 24,000
MLV Soy PCb - 7.15 ±6.15 3500
ULV Soy PCa 18:0 2.50 ±0.18 2600
ULV Soy PCb - 36.4 ±5.20 700
ULV Soy PCa - 60.5 ± 14.7 100
a. 5 mg/mL soy PC in phosphate buffer, b. 20 mg/mL soy or egg PC in phosphate buffer.
3.2.3. Effect o f FFA on entrapped volume in ULVs.
The results for the comparison of entrapped volumes for ULVs with and 
without stearic acid or a-T are shown in Figure 3.5 (with raw data tabulated and 
reported in Table A. 7 of the Appendixes). All concentration ratios of a-T or FFA 
to LH were consistent with those present in the oxidation experiments using 5 
mg/mL soy PC and 100 pM oleic acid. This figure shows the intensity of an ESR 
signal from a membrane permeable nitroxyl radical (TEMPOL) in the presence of 
a relatively membrane-impermeable, paramagnetic, spin-broadening Cr (III)
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reported in Table A.7 of the Appendixes). All concentration ratios of a-T or FFA 
to LH were consistent with those present in the oxidation experiments using 5 
mg/mL soy PC and 100 pM oleic acid. This figure shows the intensity of an ESR 
signal from a membrane permeable nitroxyl radical (TEMPOL) in the presence of 
a relatively membrane-impermeable, paramagnetic, spin-broadening Cr (III) ion. 
Any remaining ESR signal intensity after addition of Cr(lll) represents signal 
from intravesicular TEMPOL radical. Percent intensity depicted in the graph is 
explained in more detail in the section 3.4.2.4 of this chapter. The amount of 
remaining signal can further be manipulated to determine the internal or 
entrapped volume of the liposome vesicles. As illustrated in the graph (and in 
Table 3.4 below), in Tris buffer alone the signal decreases to zero near a Cr (III) 
to TEMPOL molar ratio ([Cr]/[T]) of approximately 110. For ULVs, the signal
Table 3.4. Results for measuring the entrapped volume of liposomes 
containing g-tocopherol, stearic acid, both or neither._______________
* Data obtained from minimal signal intensities observed for those data graphed in Figure 3.3.
intensity decreased to about 8.0 ±0.8% at a molar ratio of about 130. In the 
presence of FFA, however, the signal intensity decreased to approximately 6.2 ± 
0.9%. With a-T present percent intensity was 9.8 ± 0.8% at a molar ratio of 130 
and with both FFA and a-T, 8.6 ± 0.6%. Calculations for comparison of the
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Membrane Model
buffer 
ULVs 
ULVs, a-T 
ULVs, stearic acid 
ULVs, g-T, stearic acid
% Intensity
0.0
8.0 ± 0.8 
9.8 ±0.8 
6.2 ±0.9 
8.6 ± 0.6
63
3.2.4. Differential Scanning Calorimetry for ULVs with and without FFA and 
for MLVs.
DSC was conducted for liposomes containing either a-T or stearic acid or 
both. Concentration ratios of a-T or FFA to LH were comparable to those used 
in the previous oxidation experiment using 5 mg/mL ULVs and 100 pM oleic 
acid. DSC data showing the effect of a-T in liposomes are given in Table 3.5 
and Figure 3.6. Note that the addition of a-T to the liposome produces a 
broadening of the melting transition and a lower AH. A broadening effect is 
normally observed for the introduction of an impurity into the liposome.122 Here, 
Tm is the temperature of transition between the less fluid gel state and the more 
fluid liquid crystalline state (Figure 3.7), and AH is the standard enthalpy change 
of that transition.122 Calculations for comparison of the means99 using 95% 
confidence limits shows that the AH for ULVs and that for ULVs containing 200 
liM a-T were statistically different.
DSC data, shown in Table 3.6, Figure 3.8, were then compared for liposomes 
with and without stearic acid. Addition of stearic acid to the ULVs also produced 
a broadening of the transition. In this case, there was a shift to lower Tm, and a 
considerable increase in AH, indicating an increase in the fluidity of the 
liposome.119 Comparison of the means99 at 95% confidence showed that the 
observed values for AH in ULVs and in ULVs containing stearic acid were 
statistically different. Samples containing both a-T and stearic acid showed a
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Figure 3.6. Differential Scanning Calorimetry fo r ULVs Containing 
a-Tocopherol. Samples contained 20 mg/mL ULV dioleoyl PC and varying 
amounts of a-T and stearic acid.
Table 3.5. D ifferential Scanning Calorimetry fo r ULVs Containing Various
Amounts o f a-Tocopherol and Stearic Acid.
[a-T]
(UM)
[Stearate]
(uM)
Tm (°C) AH (mJ/mg)
- - -25.2 ±2.01 20.6 ±1.44
100 - -24.8 ±1.08 18.7 ±3.37
200 - -24.3 ±0.85 17.5 ±3.28
200 200 -24.0 ±0.44 20.7 ±1.37
200 400 -23.6 ±0.11 19.1 ±0.77
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"Solid" Gel State "Fluid" Liquid Crystal State
Figure 3.7. Structures of the two phases for liposomes - gel state and
liquid crystal.
decrease in AH and the Tm shifted back to the transition temperature measured 
for ULVs alone.
Finally, DSC data were compared for MLVs and ULVs (Table 3.7, Figure 3.9). 
Results show that there is a noticeable increase in AH in MLVs over ULVs. 
Interestingly, the transition recorded for MLVs was much more broad than that of 
ULVs. In addition, Tm for MLVs was lower than that of ULVs. Comparison of the 
means99 at 95% confidence, however, showed that the results obtained for 
MLVs and ULVs were not stastically different.
3.3. DISCUSSION
3.3.1. Comparison of AE for homogeneous and heterogeneous systems of 
lipid.
The kinetic analysis used here requires that the majority of peroxyl radicals 
come from substrate. Given that the rate of oxidation in the presence of 
substrate is at least an order of magnitude greater than the rate of oxidation in
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Figure 3.8. Differential scanning calorimetry for ULVs containing stearic 
acid. Samples contained 20 mg/mL ULV dioleoyl PC and varying amounts of 
a-T and stearic acid.
Table 3.6. DSC data for ULVs containing varying amounts of stearic acid
and a-T.
[a -n
(pM)
[Stearate]
(pM)
Tm (°C) AH (mJ/mg)
- -25.2 ±2.01 20.6 ±1.44
- 200 -24.9 ±0.99 21.4 ±3.47
- 400 -25.5 ±1.30 27.6 ± 3.56
100 400 -24.6 ±1.35 20.6 ±2.59
200 400 -23.6 ±0.11 19.1 ±0.77
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Figure 3.9. D ifferential scanning calorimetry fo r ULVs and MLVs. Samples 
contained 20 mg/mL ULV or MLV dioleoyl PC in phosphate buffer.
Table 3.7. D ifferential scanning calorimetry data fo r some membrane 
models.
Type o f Liposome n Tm (°C) AH
(# observations) (mJ/mg)
ULVs 5 -25.2 ±2.01 19.8 ±1.44
MLVs 3 -26.3 ±0.1 24.6 ±4.7
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its absence (Figures 2.2 and 2.5), the rate of initiation due to peroxyl radicals 
derived from the azo initiator is not important. Moreover, the reactivities of 
peroxyl radicals derived from the azo initiator and of peroxyl radicals derived 
from lipid should be the same.
Antioxidant efficiency was calculated for data reported by Niki, et al62 in their 
homogeneous system of lipid (Table 3.2). The calculated value, 12,000, was an 
order of magnitude greater than that for data reported for micelles by Strickland, 
et al (1000)“  and Pryor, et al (1800).66 By comparison, the AE calculated from 
data obtained for microsomes, reported by Krinsky, et al67 was only 110, two 
orders of magnitude less than in homogeous solution. It appears that as the 
model system becomes more membrane-like, a-tocopherol becomes less 
efficient in trapping peroxyl radicals. In addition, the AE calculated for ULVs,
700, was less than the AE calculated for MLVs, 3500. This decrease in 
efficiency could be due to less fluidity in the liposome. Fluidity in the liposome 
determines various physical characteristics of the liposome, including diffusion.
A less fluid liposome might restrict the diffusion of a-T through the membrane.
Interestingly, as discussed in section 3.3.1., the AE calculated here for 
inhibition in micelles using the [LH]so/[ArOH]so ratio (24,000) was an order of 
magnitude greater than if AE were calculated using the classical rate equation 
(4300). The [LH]so/[ArOH]so ratio calculated for data reported by Niki and his 
coworkers for inhibited oxidation in homogeneous solution (12,400) was also an 
order of magnitude greater than the value for AE that could be calculated using
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the traditional rate equation (5000).62 This suggests that the classically accepted 
mechanism and kinetics for inhibited autoxidation may not be completely valid.
DSC data obtained for MLVs and ULVs show that MLVs may be more fluid 
than ULVs (Figure 3.9, Table 3.7). Once again, a decrease in fluidity and 
decrease in diffusion of a-T may account for the smaller AE in ULVs.
Table 3.8 shows lipid-to-a-tocopherol mole ratios in several tissues, which 
ranges from 400-5000. This ratio was calculated for work presented here, using 
concentrations of a-tocopherol where inhibition was most efficient. In micelles 
the ratio is 5800, while in ULVs and MLVs the ratio is 280 and 1000, 
respectively. Inhibition data for a-tocopherol in MLVs thus show that a- 
tocopherol can only be effective in tissues such as the heart, blood serum and 
the brain, but not in the lung or liver. Inhibition data for a-tocopherol in ULVs, 
which is the more biologically realistic membrane model, show that a-tocopherol 
may not be effective in any of these tissues.
Table 3.8. Approximate lipid-to-a-tocopherol ratio in selected tissues.
Tissue mol liDid 
mol a-T
Reference
Heart 750 Mitchell, et a l123
Lung 4500 Pacht, et a l124
Liver 2000 Mitchell, et a l123125
Brain and Spinal Cord 700 Muller, et a l126
Blood Serum 450 Sokol, et a l47127
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3.3.2. Dependence of the concentration of a-tocopherol on its inhibition.
Inhibition data for a-T show that in micelles, ULVs, and MLVs inhibition by a- 
T decreases, rather dramatically in the case of ULVs and MLVs, at higher
concentrations of a-T (Figure 3.3). This could be due to competition of the ArO
for LOOH or LH to propagate the chain of free radical reactions. Cillard, et 
a l128129 saw similar results for a-tocopherol in their oxidation studies of linoleic 
acid emulsions in phosphate buffer. Results such as these were also observed 
by Bowry, Ingold, et al. To explain their results, they measured both the rates of 
formation of LOOH and the consumption of a-T in low-density lipoprotein (LDL) 
at varying concentrations of a-T. At concentrations of 1.8 pM LDL 
(approximately 2.5 mM PUFA) and greater than 66 pM a-T (lipid-to-a-T mole 
ratio of 37.9), the rate of oxidation was greater than R<* with no antioxidant 
present. The lipid-a-T mole ratio for the observation of decreased antioxidant 
efficiency of a-T in the MLV and ULV systems presented here were 
approximately 120-200 and 120-960, respectively. This decrease in inhibition at 
higher concentrations of a-T could possibly be due to prooxidation by a- 
tocopherol.
3.3.3. Effect of free fatty acids on membrane fluidity and lipid oxidation.
It has been shown that free fatty acids (FFAs) are released in damaged 
tissue. One example is the release of unesterified free fatty acid in the brain
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after trauma. 70,94 It is therefore important to study their effect on the kinetics of 
lipid peroxidation and its inhibition. This work clearly shows that the efficiency of 
inhibition by a-tocopherol is increased by addition of an essentially non- 
oxidizable fatty acid such as oleic acid to the liposome system. Oleic acid is not 
likely to participate directly in lipid peroxidation (eq 3.1), because as stated in 
chapter 1, it is the bis-allylic H atom that is abstracted from the fatty acid. Since 
oleic acid has no bis-allylic position, it can be considered to have low 
oxidizability. One possible explanation for the increased effectiveness of the 
antioxidant in the presence of oleic acid is that FFAs serve to increase fluidity 
and diffusion across the membrane.
In order to explain this theory, an understanding of the physical 
characteristics of membranes is first necessary. First of all, membrane fluidity is 
a thermodynamic description of the membrane’s phase behavior. Remember 
that membranes can exist in either an ordered gel phase or a more fluid liquid 
crystalline phase. In the gel phase, the fatty acyl chains are more tightly packed 
than in the liquid crystal.55 For this reason, a decrease in fluidity in the 
membrane generally indicates an increase in order, a physical description of the 
lipid chain packing.55 It has been shown that small ions or molecules permeate 
the membrane more readily in the membrane’s liquid crystalline phase.55 
Increases in membrane permeability thus suggest increases in fluidity. Because 
increases in fluidity and decreases :n order imply less lipid packing, greater 
diffusion of membrane proteins usually also coincide with increases in fluidity.
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Studies have shown that FFA does appreciably increase membrane 
permeability, calcium transport, and.prote»n diffusion. ®-72 M
3.3.4. Effect of FFA on entrapped volume.
Measurements for the entrapped volume of the liposome vesicle show that 
there is no significant change in entrapped volume or size of the liposome in the 
presence of either a-T, stearic acid, or both. This means that the increase in 
inhibition of oxidation by a-T was not due to a disruption of the integrity of the 
liposomes. The presence of a-T did cause a slight increase in the entrapped 
volume of ULVs, thus suggesting a small increase in chain packing in the 
liposome. It has been shown that an increase in lipid chain order actually 
causes the bilayer to become thinner.55 This could then result in an increase in 
the entrapped volume of the vesicle.55 The increase in chain packing could 
result from both the hydrogen-bonding of a-T to the polar head groups on the 
lipid and the hyrodrophobic interactions between a-Ts hydrocarbon tail and the 
phospholipid side chain (Figure 3.10).
3.3.5. Effect of FFAs and a-T on Tm.
Differential scanning calorimetry data were obtained for ULVs with and 
without a-tocopherol and stearic acid. It has been shown that Tm is dependent 
on the intermolecular attractive forces between the phospholipid 
headgroups.122,130 An increase in these attractions produces more stability in the
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liposome, thus less fluidity, and the observed Tm increases. On the other hand, 
AH depends on the distance between the hydrocarbon chains. 122,130 An increase 
in the van der Waals attractions between these hydrocarbons produces more 
stability in the liposome, thus less fluidity, and there is a decrease in the 
observed AH. Though there was no obvious change in Tm, there was a slight
CHj
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6
/ —(
5  H-bonds 
0= £-0»  HO CHj
CH3
+ FFA
'  Hydrophobic 
II Interactions
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COO*••■••+«> CHi
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Figure 3.10. Disruption of both hydrophobic interactions and hydrogen 
bonding between a-T and lipid by free fatty acid.
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decrease in AH in the presence of a-T, suggesting a-T might cause the liposome 
to be more stable or less fluid! This had been previously observed by Suzuki 
and coworkers when they measured molecular motion of a spin label in 
liposomes.131. They showed that the addition of a-T elicited less molecular 
motion of a spin label, thus showing the liposome containing a-T was more 
ordered.
Stearic acid, however, produced an increase in AH for the liposome’s gel to 
liquid crystal transition, suggesting it produces more fluidity in the membrane. 
Mabrey and Sturtevant, on the other hand, showed by DSC that addition of 
saturated fatty acids to the membrane model increased order.120 They argued 
that the introduction of the FFA into the bilayer decreases crowding in the polar 
head groups by increasing the distance between them. This, in turn, increases 
stability or order in the membrane. The difference between their data and the 
data presented in this paper is that they used a 2:1 lipid to FFA mole ratio and 
the mole ratio here was at least a 65:1 molar ratio. At the concentrations they 
used, the stearic acid - fatty acyl van der Waals attractions become more 
important than the fatty acyl - fatty acyl attractions. In the case of the data 
presented here, the stearic acid served merely as an impurity that produced less 
order in the membrane. Results similar to those shown here were also reported 
by Schaeffer and Zadunaisky when they measured diffusion of 
immunofluorescently-labeled proteins in plasma membranes treated with low
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concentration of fatty acids.73 They observed greater greater diffusion of the 
labeled protein in the presence of FFA, and thus, less order.
The resuits presented in this research indicate that there is an increase in the 
fluidity of the membrane model when FFA are present. The increase in AE for a- 
T in the presence of FFA may therefore be due to an increase in fluidity in the 
liposome. It is possible that in ULVs containing a-T, there are strong 
intermolecular forces, as mentioned earlier, that produce tighter packing in the 
liposome, and thus, less fluidity and more order (Figure 3.10). When the FFA 
are introduced, there are stronger interactions between the FFA and a-T than 
between a-T and the phospholipid. This disrupts the packing of the 
phospholipid and results in less order or more fluidity in the membrane. It is 
therefore possible that there is an increase in the diffusion of a-T through the 
more fluid membrane when FFA are present. A more mobile a-T may be thus 
more effective at trapping free radicals in damaged tissue than in normal tissue 
in vivo.
This paper shows that the choice of membrane model used to evaluate the 
effectiveness of an antioxidant is highly important. While biomembranes contain 
many components such as proteins that make interpretation of various aspects 
of lipid peroxidation difficult, membrane models provide a simple and 
uncomplicated picture of the chemistry within lipid membranes. The data clearly 
show that the effectiveness of a-tocopherol decreases dramatically as the 
membrane models become more rigid and, hence, more biologically relevant.
The effectiveness of a-tocopherol in vivo may also be questionable, especially at
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higher concentrations, where prooxidation may take place. The data do suggest 
that a-T may be more effective in damaged tissue, where FFAs are present.
3.4. EXPERIMENTAL
3.4.1. Materials.
Linoleic add (cis,cis-9,12, octadecadienoic acid), Oleic acid (c/s-9- 
octadecenoic acid), diethylenetriaminepenta-acetic acid (DTPA), L-a- 
phosphatidylcholine from frozen egg yolk (egg PC), type V-E and l-a- 
phosphatidylcholine from soybean (soy PC), type lil-S were obtained from Sigma 
Chemical Co. A crude source of soy phosphatidylcholine was obtained 
commercially in the form of L-a-lecithin capsules and was purified by flash 
column chromatography using silica gel (Chapter 2, section 2.4.1.1.). Granular 
2,2' azobis-2-amidinopropane (ABAP), type V-50, was obtained from Wako Pure 
Chemical Industries, Ltd. D,L-a-tocopherol was obtained from Hoffman-La 
Roche, Inc. TEMPOL (4-hydroxy-2,2,6,6-tetramethyl-piperidinyl-1-oxy) was a 
gift from Exxon Chemicals (8320 Stedman, Houston, TX). Potassium 
tris(oxalato)chromate(lll) trihydrate was prepared as described by Bergmann, et 
a l.115 Dioleoyl phosphatidylcholine (1,2-dioleoyl-sn-glycero-3-phosphocholine) 
was purchased from Avanti Polar Lipids (Alabaster, AL). These and all other 
incidental chemicals and solvents were of high purity and were used as 
received.
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3.4.2. Methods.
3.4.2.1. Determination of 50% inhibition concentration of a-tocopherol for 
SDS micelles using ABAP initiation.
A 15 mM solution of sodium dodecyl sulfate (SDS) was prepared in 50 mM
sodium phosphate buffer (pH 7.4). To 3 mL of this solution, linoleic acid, DTP A,
and ABAP were added, so that their final concentrations were 46.7 mM, 88.3
IiM, and 20 mM, respectively. The decrease in oxygen concentration was
followed using a Clark-type oxygen electrode. Plots of oxygen concentration as
a function of time were constructed using computer software interfaced to the
oxygen electrode via a 12 bit A/D converter. Increasing amounts of a-tocopherol
in ethanol were added a few pL at a time. After each addition, the decrease in
oxygen concentration was measured over time.
3.4.2.2. Measurement of the inhibition of oxidation in MLVs and ULVs.
Multilamellar and unilamellar vesicles were prepared by first evaporating 
under vacuum a 20 mg/mL purified soy phosphatidylcholine (PC) solution in 
chloroform and containing varying amounts of a-tocopherol. The PC was 
resuspended in 50 mM phosphate buffer, pH 7.4, so that its final concentration 
was again 20 mg/mL. MLVs and ULVs were then formed using the methods 
described for each in chapter 2, section 2.4.2.1. To 2.7 mL of either MLVs or 
ULVs in buffer, 10 pL of a 25 mM solution of DTPA in water and 120 pL of a 0.5 
M solution of ABAP in water were added, so that the final concentrations were
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88.3 fiM DTPA and 21.2 mM ABAP. After equilibration, oxygen concentration 
was monitored as described previously.
3.4.2.3. Measurement of the effect of free fatty acid on inhibition by 
a-tocopherol.
A stock solution of soy PC in chloroform containing varying amounts of a- 
tocopherol was evaporated to a film under vacuum. To demonstrate the effect 
of free fatty acids on antioxidant efficiency, this mixture for rotor evaporation also 
included oleic acid for some experiments. The mixture was resuspended in 3 mL 
of 50 mM high ionic strength phosphate buffer (containing 100 |iM DTPA), pH
7.4, so that the final concentrations were 5 mg/mL PC, 0-200 pM a-tocopherol, 
and 100 pM oleic acid in some samples. Ionic strength buffer is often used to 
prevent liposome aggregation in solution.55 Though high ionic strength 
phosphate buffer was used in this experiment, rates of oxidation in normal 
phosphate buffer were shown to be very similar. ULVs were then prepared 
using the method described in chapter 2, section 2.4.2.1. A 2.7 mL aliquot of the 
resulting ULV solution was placed in the oxygen electrode cell, and 75 (iL of a 
0.5 M ABAP solution in water was added, so that its final concentration was 13.5 
mM in the phosphate buffer. The rate of decrease in oxygen concentration was 
measured by oxygen electrode method. Plots of percent inhibition of the rate of 
oxidation versus concentration of a-tocopherol were constructed for data 
obtained with and without added oleic acid.
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3.4.2.4. Measurement of the entrapped volume in ULVs.
Entrapped volumes of the liposomes were determined according to the 
method described by Vistnes and Puskin.11* Liposomes containing the 
membrane-permeable spin label TEMPOL132 and with and without added FFA 
were extruded as described previously. Tris(oxalato)chromate(lll), a relatively 
impermeable paramagnetic ion,132 was then added in increasing concentrations 
as a spin label broadening agent. Because the solvent in these samples was 
water, special steps were taken in the aquisition of ESR spectra. Water is 
known to absorb microwave energy very strongly.133 As a result, the added 
energy causes a large decrease in relaxation time and the signal is quenched.133 
To reduce signal quenching due to water, each sample was placed in a capillary 
tube under vacuum, and the capillary tube, inside an ESR tube. The ESR 
spectrum for the spin label was obtained using an X-band Micro-Now Instrument 
Co. 8300A ESR spectrometer with a center field of 341 mT. Spectral parameters 
included a 5G modulation amplitude, a 100 G field width, a 100 s scan time, and 
a 0.1 s time constant. ESR spectra were then obtained for each of the samples. 
Signal intensity was determined by measuring peak heights using computer 
software. Percent intensity was calculated for each sample by dividing the 
signal intensity for each sample containing chromium oxalate by the intensity of 
the control sample containing no added chromium oxalate (eq 3.8). The percent 
intensity of the signals were plotted versus the mole ratio of Cr(lll) to moles of
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(3-8)
TEMPOL. Note that the liposomes were prepared in 50 mM Tris buffer, pH 7.4. 
Though deionized water may be used, phosphate buffer may not, since it 
appears to coordinates to the chromium oxalate and prevents its action as a spin 
broadening agent. Also, NaCI was added to each sample in a manner to 
maintain ionic strength throughout. Maintaining ionic strength is important in 
preventing liposome aggregation.55
3.4.2.5. Measurement of Tm using Differential Scanning Calorimetry.
Chloroform solutions of soy PC (purified as described in chapter 2, section
2.4.1.1) containing varying amounts of stearic acid and a-T were evaporated to 
a film using rotory evaporation. The samples were redissolved in 0.5 mL 50 mM 
Tris buffer, pH 7.4, such that the final concentration of PC was 20 mg/mL. 
Samples were then either sonicated to produce MLVs or extruded to produce 
ULVs (both prepared as described in chapter 2, section 2.4.2.1). Samples for 
DSC were placed in aluminum hermetic pans and DSC data were obtained using 
a Seiko DSC 220C calorimeter, operating at a scan rate of 1°C/min.
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4.1. INTRODUCTION
The goal of this research was to compare the antioxidant efficiency of 
U74006 with that of a-tocopherol in systems of noniron-dependent lipid 
peroxidation in ULV phosphatidylcholine liposomes. Furthermore, we compared 
the antioxidant efficiency of U74006 and a similar 21-aminosteroid, U74389 
(Figure 4.1), with that of the amine functionality alone, designated here as MAC- 
acetamide.
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U74006: R = CH3 
U74389: R = H
MAC-acetamide
Figure 4.1. Structures for 21 -aminosteroids used in this study.
Finally, we studied the pH dependence of the antioxidant efficiency of 
U74006. This aspect becomes increasingly important in damaged tissue, where 
the pH is known to be fairly acidic.25 We find that the antioxidant is greatly 
affected by pH and is much less efficient below pH 7.
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4.2. RESULTS
4.2.1. Comparison of the inhibitions of the 2 1 -aminosteroids with 
a-tocopherol in ULVs.
Inhibition of oxidation in ULVs by MAC-acetamide, U74006, and U74389 are 
compared in Figure 4.2 (with the raw data and their error analysis in the 
appendixes, Table A.8). Percent inhibition here represents the decrease in the 
rate of oxidation (in the presence of antioxidant) divided by the uninhibited rate 
of oxidation (with no antioxidant present). All three antioxidants, U74006, 
U74389, and MAC-acetamide, inhibited oxidation. None of the 21-aminosteroids 
tested, however, demonstrated anything close to 100% inhibition. Maximum 
inhibition was approximately 75% for U74389, 60% for U74006. and 55% for the 
MAC - acetamide.
In order to compare inhibition by a - tocopherol with that by the 
21-aminosteroids, 50% inhibition concentrations were calculated. The 50% 
inhibition concentration represents the concentration of antioxidant required to 
produce a 50% decrease in the rate of uninhibited oxidation. Thus, a smaller 
50% inhibition concentration corresponds to a more effective antioxidant. For a 
more detailed discussion of 50% inhibition concentrations and their implications, 
see chapter 3, section 3.1. As shown in Table 4.1, the 50% inhibition 
concentration for a-tocopherol, 39 pM, was less than any of the other 
antioxidants studied. The 50% inhibition concentration measured for U74389 
and U74006 were 104 and 205 pM, respectively. These values were greater 
than that of a-tocopherol by a factor of 2 - 3. Finally, the 50% inhibition
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and C) U74006. Systems contained 21.2 mM ABAP and 88.3 pM DTPA in 20 mg/mL ULV soy PC. Rates of oxidation 
were measured by oxygen consumption method using an oxygen electrode.
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concentration calculated for MAC-acetamide was 206 uM, greater than that of a- 
toccphero! by a factor of 5. In this liposome system, cc-tocophercl was thus a 
much more effective antioxidant than either of the 21-aminosteroids or 
MAC-acetamide.
Table 4.1. Comparison of Inhibition by 21-Aminosteroids and a- 
Tocopherol in ULV Liposomes.
Antioxidant 50% Inhibition Concentration
(mM)
MAC-acetamide 206 ± 38
U74389 104 + 7
U74006 205 ± 81
a-Tocopherol 36 ±5
Inhibition was measured in 20 mg/mL ULV soy PC in 50 mM phosphate buffer, pH 7.4, and 
containing 21.2 mM ABAP and 88.3pM DTPA.
4.2.2. Effect of pH on inhibition by U74006.
As shown in Figure 4.3, the antioxidant effectiveness of U74006 decreased 
dramatically when the pH changed from 7.0 to 6.5. In particular, the 50% 
inhibition concentration increased from 100pM at pH 7.0 to 200pM at pH 6.5.
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This means that the antioxidant was only half as effective at pH 6.5 as compared 
to pH 7.0.
4.3. DISCUSSION
Results presented here show that U74389 and U74006 exhibit about the 
same antioxidant effectiveness in ABAP-initiated ULV liposomes. This is shown 
in Figure 4.2 and Table 4.1. Furthermore, U74389 demonstrated the same or 
perhaps a greater antioxidant effectiveness than MAC-acetamide. If indeed the 
21-aminosteroids are better antioxidants than MAC-acetamide, this could be due 
to the added benefit of the steroid functionality on the U74389. Steroids such as 
cholesterol have been shown to be membrane stabilizers, in that they bring 
about more order in the membrane. 134,135 Creating a more rigid bilayer may 
decrease the number of free radicals capable of diffusing through to the 
hydrophobic region of the membrane to initiate lipid oxidation. A second 
explanation could be that addition of the steroid affords the antioxidant more 
favorable partitioning into the hydrophobic lipid bilayer where lipid peroxyl 
radicals reside.
In comparison to a-tocopherol, U74006 and U74389 are not as effective in 
inhibiting oxidation. In ULV liposomes, a-tocopherol proved to be more effective 
than MAC-acetamide and the 21 -aminosteroids by factors of 3-5. Neither the 
21-aminosteroids nor MAC-acetamide, however, was ever completely effective in
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the liposomes, in that percent inhibition never reached 100% in either case.
This means that the antioxidants do not shut down autoxidation in this liposomal 
membrane model.
Finally, the efficiency of U74006 appears to have associated with it a very 
large pH dependence. In fact, the antioxidant efficiency of U74006 decreases 
by half between pH 6.5 and pH 7.0. This means that in oxidatively damaged 
tissues where the pH is shown to be somewhat acidic,25 U74006 may be even 
less effective at terminating lipid peroxyl radicals.
This research thus indicates that while U74006 and U74389 do exhibit 
antioxidant activity, they are not as effective as a-tocopherol in the liposome 
model. Furthermore, in oxidatively damaged tissue in vivo where the pH is 
reduced, the 21-aminosteroids might actually be very inefficient antioxidants. It 
is possible that the observed decrease in antioxidant effectiveness at lower pH is 
due to a change in the geometry of the molecule when the antioxidant becomes 
protonated. The protonated molecule may assume a geometry that decreases 
its ability to insert into the membrane to both trap free radicals and to increase 
membrane stability.
Though the 21-aminosteroids were shown here to be somewhat ineffective, 
they have been shown to be effective clinically. It is therefore possible that they 
inhibit lipid peroxidation by some other non-chemical mechanism.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
89
4.4. EXPERIMENTAL
4.4.1. Materials:
Soy phosphatidylcholine was purified from lecithin tablets using flash-column 
chromatography (described in Chapter 2, section 2.4.1.1). MAC-acetamide, or 
U98982 (4-(2,6-di-1 -pyrrolidinyl-4-pyrimidinyl)-1 -piperazinyl acetate), and the 
21 -aminosteroids U74389 (21 -[4-(2,6-di-1 -pyrrolidinyl-4-pyrimidinyl)-1 - 
piperazinyl]-pregna-1,4,9(11 )triene-3,20-dione) and U74006 (21-£4-(2,6-di-1 - 
pyrrolidinyl-2-pyrimidinyl)-1 -piperazinyl]-16.alpha.)-pregna-1,4,9(11 )-triene-3,20- 
dione) were gifts from Pharmacia Upjohn, Inc. Note that U74389 and U74006 
were the organic soluble versions of U74389G and U74006F and were used 
here for experimental convenience. Diethylenetriamine penta-acetic acid 
(DTPA) was purchased from Sigma Chemical Co. Granular 2,2' azobis-2- 
amidinopropane (ABAP), type V-50, was obtained from Wako Pure Chemical 
Industries, Ltd. These and all other incidental chemicals used were of high 
purity and were used as obtained.
4.4.2. Methods:
4.4.2.1. Measurement of the inhibition by U74389, U74006, and MAC - 
acetamide in ULV soy PC liposomes.
ULVs containing varying concentrations of U74006, U74389, or MAC- 
acetamide were prepared by first rotory evaporating together a solution of soy 
PC in chloroform and various amounts of a chloroform stock solution of the 
antioxidant to be studied. A 20 mg/mL soy PC solution was then formed by
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redissolving the lipid in the appropriate amount of 50 mM phosphate buffer, pH
7.4. ULVs were then prepared using the method described in chapter 2, section
2.4.2.1. Diethyienetriamine penta-acetic acid (DTPA), an iron chelator, and 2,2'- 
azobis-2-amidinopropane (ABAP), an azo initiator, were then added so that the 
final solution contained 88.3 pM DTPA and 22 mM ABAP. The rate of oxidation 
was followed by measuring the decrease in oxygen concentration versus time 
using a Clark-type oxygen electrode interfaced via a 12 bit A/D converter to 
computer software.
4.4.2.2. Evaluation of the effect of pH on inhibition by U74006.
The effect of pH was determined in samples of 20 mg/mL ULV soy PC 
liposomes containing U74006, prepared as described in chapter 2, section
2.4.2.1. To evaluate the AE of the 21-aminosteroids as a function of pH, the 
samples were extruded in 50 mM phosphate buffer of varying pH. Oxidation 
was initiated using ABAP and its rate was followed by oxygen electrode method.
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Important to the study of lipid peroxidation is the use of membrane models. 
Simple and uncomplicated, biologically realistic membrane models allow for a 
quick and easy elucidation of many aspects of both lipid peroxidation and its 
inhibition.90 The primary goal of this research was to explore lipid peroxidation 
and its inhibition in membrane models. To accomplish this objective, three sets 
of experiments were performed. First of all, the kinetics of lipid peroxidation in 
two liposome models, unilamellar vesicles (ULVs) and multilamellar vesicles 
(MLVs), were studied. The results of these experiments were presented in 
chapter 2. Secondly, the inhibition of lipid peroxidation by a-tocopherol in MLVs 
and ULVs was investigated. Furthermore, the effects of membrane structure and 
free fatty acids on this inhibition were explored. The discussion of these 
experiments was covered in chapter 3. Finally, the inhibition of lipid peroxidation 
in liposomes by a group of synthetic antioxidants called 21-aminosteroids as 
compared to inhibition by a-tocopherol was presented in chapter 4.
5.1. Kinetics of lipid peroxidation in membrane models.
Data resulting from this research as well as that found in the literature show 
that the kinetics of homogeneous solution and of micelles may not be the same 
as those of the more biologically realistic membrane models studied here - 
liposomes (Table 5.1 j.58-63*5. it was observed that the kinetics of autoxidation 
were different in the large ULVs and in the MLVs studied here.
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Table 5.1. Comparison of orders obtained for measuring the kinetics of
lipid peroxidation in membrane models.__________________________
Membrane Model [ABAP] [LH] [OJ
Homogeneous 0.50a 1.00 0b
SDS micelles 0.50* 1.00 0b
MLVs 1.37 ± 0.10 0.76 ±0.10 0.09 ±0.05
ULVs 1.35 ±0.18_______0.17 ±0.10_______ 0 05 ±0.01
a. Data reported by Pryor, et a l.30 b. As reported by Burton, Ingold, and others.1JO
One explanation for the kinetic differences between all of the model systems 
compared here may be the differences in O2 concentrations in the membrane 
models. While autoxidation was shown to be virtually independent of [0 2] in 
solution and in micelles, Barclay and Ingold noticed that the rate law for 
autoxidation in liposomes is slightly affected by the oxygen partial pressure.100 
They argue that as the oxygen partial pressure decreases, chain transfer may 
begin to occur by a cross termination mechanism (eq 5.2), as opposed to 
termination by coupling of two lipid peroxyl radicals (eq 5.1).
2LOO' -----------► non-radical products (5 1 )
LOO* + L *-----------► non-radical products ^5 2 )
Cross terminations such as that in eq 5.2 in addition to the reaction in eq 5.3 
might become increasingly important in oxygen-deprived membranes, where the
ratio of L’ to LOO’ increases.100 There may likewise be a dependence of
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autoxidation on [O2] in the membrane models studied here (Table 5.1). 
Statistically, the orders in 0 2 in both MLVs and ULVs are different from zero.
2L- -----------► non-radical products ( 5  3 )
While Barclay's group observed classical kinetics in their membrane models 
of small ULVs and MLVs, they did note that ULVs were more susceptible to 
oxidation than MLVs.102 They rationalized this based on lipid chain packing in 
the two models. They argue that the higher oxidative susceptibility of ULVs is 
due to higher local concentrations of oxidizable methylene groups. This would 
then result in higher rates of propagation.
The large order with respect to Ri observed in both MLVs and ULVs (Table
5.1) could be due to induced decomposition.137 With the occurrence of induced 
decomposition the order in Rj has been shown to be greater than 3/2. 137
Induced decomposition is a bimolecular process in which free radicals attack 
a non-radical compound and cause it to decompose.137 One plausible 
mechanism for induced decomposition in the MLVs and ULVs studied here is
given in eq 5.4. In this mechanism, LOO' attacks the peroxidic (O-O) bond of
the non-radical LOOH. It is possible that as lipid chains become more restricted, 
the probability of a lipid peroxyl radical encountering another of its kind for 
termination is much smaller.
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LOO- + LOOH ^  (LOOOH) + LO
I ► LO- + -OOH
Overall:
LOO- + LOOH ---------- ► 2LO- + -OOH (5 .1 )
Overall, ULVs appear to be more kinetically different from the classical rate 
law than MLVs. This may be because MLVs are more fluid and ULVs, more 
rigid. It is thus reasonable to assume that ULVs are both the most biologically 
and kinetically realistic membrane models of the model systems compared here.
5.2. Inhibition of lipid peroxidation by a-tocopherol.
Fortunately, the body possesses several natural antioxidants to prevent 
against oxidative damage.7 These include a-tocopherol (Vitamin E), p-carotene, 
ascorbic acid, and enzymes such as superoxide dismutase and catalase, to 
name a few .7 Recently, a pharmaceutical movement toward developing 
synthetic antioxidant drugs has emerged. 722-“ 91 The use of realistic membrane 
models is important to the study of antioxidants, as they provide a route to 
simple and fast comparisons of the effectiveness of antioxidants. The results 
presented in this dissertation suggest that the choice of membrane model is 
critical, as the kinetics of inhibition in each may be quite different. In this set of 
experiments, the antioxidant efficiency of a-T was therefore determined for
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oxidation in SDS micelles, MLVs and ULVs. These efficiencies were compared 
with others reported in the literature for the same or different systems.
The antioxidant efficiency of a-T was measured here by comparing 50% 
inhibition concentrations. This value was used for comparison because it can be 
calculated without first determining the rate equation for inhibited oxidation.
There was a dramatic decrease in the antioxidant efficiency of a-T from micelles 
to liposomes.58® 6667 Comparing these results with others in literature, 
antioxidant efficiency decreases from homogeneous solution to micelles, and 
from micelles to microsomes and liposomes. 58-62 66-68 Perhaps as the model 
becomes more rigid, it becomes increasingly difficult for a-T to encounter and 
trap peroxyl radicals.
Oxidation data show that a-T is more efficient in MLVs than in ULVs. DSC 
data suggest that MLVs may be more fluid than ULVs. MLVs should thus allow 
a-T to diffuse more readily. An interesting result observed from DSC data was 
the decrease in the fluidity of ULVs in the presence of a-T. This may be 
evidence that in liposome models a-T is more restricted and less efficient at 
encountering and trapping free radicals than it is in homogeneous solution.
The inhibition data for a-tocopherol do suggest that a-T may not be very 
efficient in real tissues. In liposomes, especially in ULVs, a-T was only 
completely efficient at concentrations greater than that that exists is real tissues.
It is difficult to predict what the efficiency of a-T may be in real tissues, though, 
since real membranes contains a large amount of protein, and these proteins 
have been shown to participate in autoxidation.138
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Interestingly, at high concentrations of a-T, antioxidant efficiency decreased 
substantially. This was also observed by several other groups for both a-T and 
Trolox. 128>129'139-141 Bowry and Ingold have reasoned that this is probably due to 
chain propagation via the tocopheroxyl (phenoxyl) radical.139-140142 They further 
argue, perhaps incorrectly, that at high concentrations, the persistent 
tocopheroxyl (phenoxyl) radical located in lipophilic region rarely encounters free
radicals (LOO‘) residing in aqueous solution. This assumption is probably
based on the “Floating”  Peroxyl Radical Hypothesis.101,143 It has been theorized 
that once formed, the peroxyl radical, shown to have a very high dielectric 
constant, “floats" toward the aqueous layer to hydrogen bond with water.101,143 
The phenoxyl radical generated from a-T then instead terminates by abstracting 
a hydrogen atom from a molecule of lipid in close proximity to produce a chain- 
propagating lipid alkyl radical.139 The problem with the “Floating" Peroxyl 
Radical Hypothesis is that it suggests a decrease in order or increase in fluidity 
during autoxidation. Moderate levels of lipid peroxidation, however, were shown 
to increase order and decrease membrane permeability and fluidity in 
microsomes.144
Perhaps a better explanation comes from analysis of oxidation products for a- 
T, reported by Leibler, et a l.48 Leibler observed an a-T oxidation product that 
could be the result of a prooxidation reaction (Figure 5.3). In this mechanism the
phenoxyl radical produced by H-atom abstraction by LOO', now of high 
concentration, reacts with LOO* to form an epoxy alkyl radical and L0‘ by p-
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scission (Figure 5.3). The epoxy alkyl radical then reacts with O2 to produce a 
peroxyl radical. This a-tocopherol-derived peroxyl radical can then abstract a H- 
atom from another molecule of lipid to terminate itself and produce a chain 
propagating lipid alkyl radical. This is an important consequence, because in
this case a-T has terminated only one LOO' and has generated one LO' and one
L\
LOO*
t o . - * '
H
Figure 5.3. Oxidation products of a-T that may suggest mechanism for
prooxidation.
It was observed that a-T was highly effective at low concentrations in the 
presence of free fatty acids. This could infer that a-T may be more effective in 
damaged tissue, where FFA have been shown to be released. 70,94 This increase 
in antioxidant efficiency may be due to an increase in fluidity in the membrane 
when FFA are present. A similar increase in fluidity in the membrane in the 
presence of FFA was observed by. Schaeffer and Zadunaisky, measuring 
diffusion of immunofluorescently-labeled proteins in plasma membranes.73 This
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suggests that lipid packing is smaller in the presence of FFA. DSC data 
presented here likewise show that FFAs produce more fluidity in the liposome.
A more fluid lipid bilayer may allow for greater diffusion of a-T through the 
membrane to terminate lipid peroxyl radicals.
5.3. Inhibition of oxidation by 21-aminosteroids.
The recent trend toward developing synthetic antioxidant drugs seems 
promising.7 Pharmacia & Upjohn, Inc., have developed an antioxidant, the 21- 
aminosteroid U74006, it hopes will prove effective against CNS trauma and 
prevent tissue damage following stroke.145
Antioxidant efficiencies of a-T, U74006, U74389, and MAC-acetamide,the 
acetylated pyrimidine with no attached steroid, were compared in ULVs. It was 
observed that none of the 21 -aminosteroids studied were as effective as a-T. In 
addition, none of the 21-aminosteroids studied were completely efficient, in that 
percent inhibition never reached 100%. Of the 21-aminosteroids, U74389 was 
more effective than either U74006 or MAC-acetamide by a factor of 2.
The antioxidant efficiency of U74006 was shown here to decrease by half 
from pH 7.0 to pH 6.5. This could be due to a change in geometry in the 
molecule after protonation. The protonated molecule may assume a “bent” 
orientation that penetrates the liposome only minimally. It is thus possible that 
U74006 may be ineffective in already damaged tissues, which are typically of 
lower pH .25 This finding, in conjunction with its low efficiency in comparison to a-
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T, leave doubt as to the effectiveness of this drug as an antioxidant, effective by 
only a chemical mechanism. Since it has been shown effective in vivo in 
preventing reperfusion injury,92146 it is possible that it inhibits lipid peroxidation 
by some other mechanism. Perhaps it inhibits one of the biological processes 
involved in ischemia.
5.4. Summary.
This dissertation thus demonstrates that the choice of membrane model for 
evaluating lipid peroxidation is critical, as the kinetics of each are quite different. 
Comparing liposomes and other membrane models, it is shown here that a-T 
appears effective in homogeneous solution, micelles, and liposomes modeling 
damaged membranes. Its antioxidant efficiency, however, is much lower in 
liposome models for undamaged membranes. Finally, while the effort toward 
developing synthetic antioxidant CNS drugs is promising, more work may need 
to be done to find an antioxidant that is at least as effective as a-T and whose 
activity has little or no pH dependence.
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Table A.1. Tabulated results for the effect of media on the rate of 
decomposition of ABAP, shown in Figure 2.2.___________
Media
Phosphate
buffer3
SDS micelles
MLV
hydrogenated
PCc
[ABAP]
(mM)
0.0
3.3
5.0
6.7
10.0
12.5
25.0
30.0 
0.0 
0.8
1.7
2.5
3.3
4.2
5.0
6.7
8.3
0.0
3.6
5.2
7.0
10.5 
13.9 
15.3
17.2
20.2
20.6 
23.8
25.0 
27.2 
29.7
32.0
n
{# observations)
2
1
1
1
1
4
1
2
2
1
2
1
2
1
2
1
1
2
1
1
2
2
2
1
2
1
2
2
1
1
1
1
Rate ± o
(pM/sec)
0.0016 + 0.0000 
0.0036 
0.0079 
0.0061 
0.0080 
0.0114 ±0.0008 
0.0181 
0.0207 ±0.0036 
0.0011 ± 0.0002 
0.0015 
0.0014 ±0.0002 
0.0027 
0.0024 ±0.0012 
0.0023 
0.0036 ± 0.0008 
0.0045 
0.0048
0.0004 ± 0.0002 
0.0005 
0.0035 
0.0044 ± 0.0051 
0.0046 ±0.0018 
0.0060 ± 0.0007 
0.0072 
0.0074 ±0.0014 
0.0107 
0.0082 ± 0.0028 
0.0097 ± 0.0048 
0.0116 
0.0202 
0.0104 
0.0176
(table con’d)
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ULV hydrogenated
pCd 0.0 3 0.0021 ±0.0012
4.1 1 0.0022
5.5 1 0.0019
8.8 1 0.0063
10.9 1 0.0040
12.2 1 0.0077
16.1 1 0.0120
17.2 1 0.0087
20.0 1 0.0143
21.3 1 0.0097
23.8 1 0.0157
25.4 1 0.0120
27.6 1 0.0127
30.2 1 0.0146
31.3 1 0.0150
Samples contained increasing concentrations of ABAP in the following systems: a. 50 mM
phosphate, pH 7.4,83.3 pM DTPA b. 0.5 M SDS micelles in buffer, 83.3 pM DTPA c,d. 20
mg/mL MLV or ULV hydrogenated egg PC in buffer, 83.3 pM DTPA. Data were obtained using
the oxygen electrode method.
Table A.2. Tabulated data obtained fo r measuring the order in ABAP,
shown in Figure 2.4.
Membrane Model log[ABAP] n log[Rate]
(# observations)
SDS micelles -2.60 2 -7.36 ± 0.01
-2.30 2 -7.21 ±0.00
-2.13 2 -7.12 ± 0.05
-2.00 2 -7.06 ± 0.04
-1.90 2 -7.02 ±0.03
-1.82 2 -6.98 ± 0.03
MLVs -2.60 1 -8.47
-2.30 1 -7.88
-2.13 1 -7.81
-2.00 1 -7.61
-1.90 1 -7.40
-1.82 1 -7.25
ULVs -2.60 1 -8.37
-2.30 2 -8.629 ± 0.45
-2.13 2 -7.99 ±0.25
-2.00 1 -7.69
-1.90 2 -7.44 ± 0.16
-1.82 1 -7.40
-1.76 1 -7.33
Samples contained varying concentrations of ABAP in a. 0.5 M SDS in buffer, 46.7 mM linoleic 
acid, 83.3 pM DTPA, b,c. 20 mg/mL MLV or ULV soy PC in buffer, 83.3 pM DTPA. Data were 
obtained using the oxygen electrode method.
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Table A.3. Tabulated data fo r measuring the order in LH, shown in Figure
2.5._____________________________________________________________
Membrane Model
MLVs
ULVs
log[LH] n
(# observations)
log[Rate] ± 0
-3.00 1 -7.46
-2.60 1 -7.22
-2.30 2 -7.17 ±0.07
-2.13 1 -7.02
-2.00 2 -7.14 ±0.08
-1.90 1 -7.08
-1.82 2 -6.93 ± 0.26
-1.76 1 -7.01
-1.70 2 -6.88 ±0.28
-2.60 1 -7.24
-2.30 1 -7.32
-2.00 1 -7.21
-1.90 1 -7.09
-1.82 1 -7.05
-1.76 2 -7.13 ±0.27
-1.70 3 -7.14 ±0.03
Samples contained varying concentrations of either MLV or ULV soy PC diluted with 
hydrogenated egg PC to control LH concentration. Samples also contained 83.3 pM DTPA and 
21.2 mM ABAP. Data were obtained using the oxygen electrode method.
Table A.4. Tabulated data fo r measuring dependence o f [O2] on the rate o f 
oxidation in MLVs and ULVs, shown in Figure 2.6.______________________
Membrane Model
MLVs
ULVs
[OJ
(pM)
62.5 
250 
1250
62.5 
250 
1250
(# observations)
3
3
3
3
3
3
R o x  ± a
(pM/sec)
0.1133 ± 0.0773 
0.1108 ±0.0790 
0.1453 ±0.0515 
0.0714 ±0.0188 
0.0732 ± 0.0051 
0.08173 ±0.0277
Samples contained 20 mg/mL ULV or MLV soy PC in phosphate buffer, 83.3 pM DTPA, and 21.2 
mM ABAP. Samples were bubbled with gas of varying O2 concentrations. Data were obtained 
using the oxygen electrode method.
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Table A.5. Tabulated data fo r inhib ition by a-T in SDS micelles, MLVs, and
ULVs, shown in Figure 3.3.
Membrane Model [a-T] (nM) n
(# observations)
% Inhibition ± a
SDS Micelles3 1.5 1 26.8
2.0 2 63.2 ±2.97
2.5 3 73.2 ±10.4
3.0 2 83.3 ±13.7
5.0 5 67.3 ±15.3
7.5 3 83.3 ±10.1
10.0 4 89.5 ±4.4
12.5 2 85.7 ±13.2
15.0 4 87.2 ±1.5
20.0 5 63.9 ±15.9
25.0 3 60.6 ±9.0
30.0 1 69.3
MLVs 5 1 18.4
10 1 79.7
15 1 86.0
25 2 107.6 ±1.8
50 2 99.7 ± 35.6
60 1 87.1
75 2 82.3 ±12.3
90 1 80.6
100 2 74.7 ±1.7
125 1 47.6
150 2 30.8 ±15.5
200 2 23.4 ±4.7
ULVsc 15 1 5.1
25 1 13.8
35 1 47.9
50 1 96.5
60 1 112.4
70 3 97.6 ±26.8
75 2 114.5 ±14.8
80 3 98.5 ±41.5
90 4 102.8 ±31.9
100 3 100.9 ±43.8
110 1 109.4
125 2 93.4 ±19.3
150 1 89.9
200 1 55.9
Samples contained increasing concentrations of a-T in either a. 15 mM SDS micelles in buffer,
46.7 mM linoleic acid, 80 jiM DTPA, and 20 mM ABAP, and b, c. 20 mg/mL MLV or ULV soy 
PC in buffer, 21.2 mM ABAP, and 88.3 nM DTPA. Data were obtained using the oxygen 
electrode method.
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Table A.6. Tabulation of data measuring the inhibition of a-T with and 
without free fatty acids, shown in Figure 3.4.____________________
Membrane Model [a-T]
(pM)
n
(# observations)
% Inhibition ± cr
ULVs, -FFA 0 1 0
25 1 22.5
75 1 56.9
100 1 74.9
175 1 98.4
ULVs, +FFA 0 1 0
5 2 65.9 ±30.9
10 1 81.9
50 1 109.8
100 2 88.0 ±14.1
150 2 97.3 ±13.5
200 1 111.1
System contained 5 mg/mL ULV soy PC in phosphate buffer, 100 nM DTPA, 5 mM ABAP, and
100 fiM oleic add in some samples. Data were obtained using the oxygen electrode method.
Table A.7. Tabulation of data obtained for measuring the entrapped 
volume of ULVs, shown in Figure 3.5.
Membrane Model [Cr]/[T) n
(# observations)
% Intensity ± a
Tris buffer 0 1 100
5 1 69.0
10 1 48.5
20 1 19.5
25 2 16.7
30 1 12.3 ±4.2
40 1 6.1
50 3 4.3 ±2.0
60 2 3.8 ±2.7
70 2 2.6 ±1.1
80 3 1.7 ±0.6
90 1 1.4
100 3 1.4
110 1 0.9
120 1 0.9
130 1 0
(table con’d)
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ULVs
ULVs, a-T
ULVs, stearic 
acid
ULVs, a-T, 
stearic acid,
0 2 100
10 2 26.8 ±2.7
30 i 17.7
40 1 13.7
50 3 9.1 ±1.8
60 2 10.2 ±2.6
70 4 8.2 ±2.5
80 4 7.7 ±2.4
90 2 10.0 ±3.4
100 2 8.8 ± 0.5
110 2 8.5 ±0.5
120 2 7.9 ± 0.2
130 2 7.1 ±0.9
0 1 100
40 1 16.2
60 1 11.3
80 1 11.5
90 1 2110.7
100 1 10.6
110 1 9.6
120 1 9.5
130 1 8.8
0 1 100
60 3 7.6 ±0.5
80 2 8.0 ±1.7
90 3 7.3 ±0.3
100 4 7.0 ±1.3
110 4 6.8 ±1.2
120 4 6.4 ±1.4
130 4 5.9 ±1.4
0 1 100
80 1 9.5
90 1 9.5
100 1 8.8
110 1 8.7
120 1 8.4
130 1 7.8
Systems contained 60 mg/mL soy PC in Tris buffer containing 0.5 mM TEMPOL, and with and 
without 300 |iM a-T, and 1200 pM stearic acid. Ionic strength was maintained throughout.
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Table A.8. Tabulated data fo r measuring the inhibition by MAC-acetamide, 
U74389, and U74006, shown in Figure 4.2.____________________________
A niioxidani [Antioxidant] n % inhibition ± o
OiM) (# observations)
MAC-acetamide 25 1 19.1
50 1 30.0
100 1 44.0
125 1 46.1
150 1 37.7
175 1 48.4
200 1 56.9
U74389 25 1 26.9
50 15.0+4.0
70 1 49.0
80 1 35.9
100 1 42.9
125 66.0 ±15.0
150 39.9 ±20.2
175 1 57.0
200 1 73.4
U74006 10 1 18.3
50 1 17.4
75 1 43.1
100 51.6 ±14.7
150 1 56.7
175 1 44.9
200 1 54.5
Samples contained 21.2 mM ABAP and 83.3 |iM DTPA in 20 mg/mL ULV soy PC. Data were 
obtained using the oxygen electrode.
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